<SEC-DOCUMENT>0001104659-21-010314.txt : 20210201
<SEC-HEADER>0001104659-21-010314.hdr.sgml : 20210201
<ACCEPTANCE-DATETIME>20210201171949
ACCESSION NUMBER:		0001104659-21-010314
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20210201
DATE AS OF CHANGE:		20210201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-252625
		FILM NUMBER:		21577832

	BUSINESS ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312
		BUSINESS PHONE:		610-727-3913

	MAIL ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>tm213941-1_s3.htm
<DESCRIPTION>S-3
<TEXT>
<html>
  <head>
    <title>tm213941-1_s3 - none - 2.4218381s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:center; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">As filed with the Securities and Exchange Commission on February&#160;1, 2021</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:right; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">Registration No. 333-&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font>&#8203;</div>
        <div style="margin-top:1.333pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.33333333333333pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.5pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.5pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:14.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">UNITED STATES </font>
          <br >
          <font style="letter-spacing:-0.28pt;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:-1.21pt; text-align:center; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:3.133pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 3.13333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:14.5pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">FORM S-3</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:0.8pt; text-align:center; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">REGISTRATION STATEMENT </font>
          <br >
          <font style="letter-spacing:-0.15pt;">UNDER </font>
          <br >
          <font style="letter-spacing:-0.15pt;">THE SECURITIES ACT OF 1933</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:3.133pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 3.13333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:8.5pt;font-size:14pt;">
          <font style="font-weight:bold;letter-spacing:-0.28pt;">Annovis Bio, Inc.</font><font style="letter-spacing:0.28pt;"> </font>
          <br >
          <font style="font-size:8pt;letter-spacing:0.16pt;">(Exact name of registrant as specified in its charter)</font><font style="letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:3.3pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 3.29999999999998pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;margin-top:2pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:264.66pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.16pt;">Delaware</font><font style="letter-spacing:0.16pt;"> </font>
                <br >
                <font style="letter-spacing:0.16pt;">(State or other jurisdiction of </font>
                <br >
                <font style="letter-spacing:0.16pt;">incorporation or organization) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:264.65pt;">
              <div style="text-align:center;">
                <font style="font-weight:bold;letter-spacing:-0.16pt;">26-2540421</font><font style="letter-spacing:0.16pt;"> </font>
                <br >
                <font style="letter-spacing:0.16pt;">(I.R.S. Employer </font>
                <br >
                <font style="letter-spacing:0.16pt;">Identification Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.7pt; text-align:center; width:541.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">1055 Westlakes Drive, Suite 300 </font>
          <br >
          <font style="letter-spacing:-0.15pt;">Berwyn, PA 19312 </font>
          <br >
          <font style="letter-spacing:-0.15pt;">(610) 727-3913</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
          <br >
          <font style="font-weight:normal;font-size:8pt;letter-spacing:0.16pt;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:2.7pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 2.70000000000002pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.7pt; text-align:center; width:541.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">Maria Maccecchini, Ph.D. </font>
          <br >
          <font style="letter-spacing:-0.15pt;">President and Chief Executive Officer </font>
          <br >
          <font style="letter-spacing:-0.15pt;">Annovis Bio, Inc. </font>
          <br >
          <font style="letter-spacing:-0.15pt;">1055 Westlakes Drive, Suite 300 </font>
          <br >
          <font style="letter-spacing:-0.15pt;">Berwyn, PA 19312 </font>
          <br >
          <font style="letter-spacing:-0.15pt;">(610) 727-3913</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
          <br >
          <font style="font-weight:normal;font-size:8pt;letter-spacing:0.16pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:2.71pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 2.71000000000004pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.7pt; text-align:center; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">Copies to:</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:3pt; text-align:center; width:541.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">Kathleen M. Shay, Esq. </font>
          <br >
          <font style="letter-spacing:-0.15pt;">Darrick M. Mix, Esq. </font>
          <br >
          <font style="letter-spacing:-0.15pt;">Duane Morris LLP </font>
          <br >
          <font style="letter-spacing:-0.15pt;">30 South 17</font><font style=" position:relative; bottom:3pt;font-size:5.5pt;letter-spacing:-0.11pt;">th</font><font style="letter-spacing:-0.15pt;"> Street </font>
          <br >
          <font style="letter-spacing:-0.15pt;">Philadelphia, PA 19103 </font>
          <br >
          <font style="letter-spacing:-0.15pt;">(215) 979-1227</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:2.633pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 2.63333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3.81pt; text-align:center; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement.</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:3pt; width:521.31pt; line-height:8pt;">
          <font style="letter-spacing:0.15pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.&#160;&#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act: </font>
        </div>
        <table style="width:501.31pt;height:30pt;margin-left:20pt;margin-top:3.5pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:244.66pt;">
              <div style=" float:left; line-height:8pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Large accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:8pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.16pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:244.65pt;">
              <div style=" float:left; line-height:8pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:8pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.16pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:244.66pt;">
              <div style=" float:left; line-height:8pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Non-accelerated filer</font>
                <br >
              </div>
              <div style=" line-height:8pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.16pt;">&#9746; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:244.65pt;">
              <div style=" float:left; line-height:8pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Smaller Reporting Company</font>
                <br >
              </div>
              <div style=" line-height:8pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.16pt;">&#9746; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:244.66pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:244.65pt;white-space:normal;">
              <div style=" float:left; line-height:8pt; text-align:left; width:120pt;white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Emerging Growth Company</font>
                <br >
              </div>
              <div style=" line-height:8pt; text-align:left; margin-left:120pt;">
                <font style="letter-spacing:0.16pt;">&#9746;</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:10.8pt; width:541.31pt; line-height:7.5pt;">
          <font style="letter-spacing:0.15pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. &#9746; </font>
        </div>
        <div style="margin-top:3.643pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 3.64333333333343pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:3.8pt; text-align:center; width:541.31pt; line-height:8pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">CALCULATION OF REGISTRATION FEE</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <table style="width:541.31pt;height:82pt;margin-top:-7.21000000000004pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;">
            <td style="padding:0pt;border-bottom:3px double #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:3px double #000000;padding:0pt 0pt 1.25pt 0pt; width:0pt;" colspan="9">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.25pt 0pt 1.25pt 0pt; width:293.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.15pt;">Title of each class of Securities </font>
                <br >
                <font style="letter-spacing:-0.15pt;">to be Registered</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.25pt 0pt 1.25pt 0pt; width:173.77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.15pt;">Amount to be Registered/Proposed maximum</font>
                <br >
                <font style="letter-spacing:-0.15pt;">offering price per unit/proposed maximum offering price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.25pt 0pt 1.25pt 0pt; width:50.88pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.15pt;">Amount of</font>
                <br >
                <font style="letter-spacing:-0.15pt;">Registration Fee </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:293.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Common stock, $0.0001 par value per share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:173.77pt;">
              <div style="text-align:center;font-size:5.5pt;">
                <font style=" position:relative; bottom:3pt;letter-spacing:0.11pt;">(1)</font><font style="font-size:7.5pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:50.88pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.15pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:293.66pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.15pt;">Preferred stock, $0.0001 par value per share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:173.77pt;">
              <div style="text-align:center;font-size:5.5pt;">
                <font style=" position:relative; bottom:3pt;letter-spacing:0.11pt;">(1)</font><font style="font-size:7.5pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:50.88pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.15pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:293.66pt;text-align:left;">
              <font style="letter-spacing:0.15pt;">Warrants </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:173.77pt;">
              <div style="text-align:center;font-size:5.5pt;">
                <font style=" position:relative; bottom:3pt;letter-spacing:0.11pt;">(1)</font><font style="font-size:7.5pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:50.88pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.15pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:293.66pt;text-align:left;">
              <font style="letter-spacing:0.15pt;">Units </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:173.77pt;">
              <div style="text-align:center;font-size:5.5pt;">
                <font style=" position:relative; bottom:3pt;letter-spacing:0.11pt;">(1)</font><font style="font-size:7.5pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1.25pt 0pt; width:50.88pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.15pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:7.5pt;">
            <td style="padding:0pt;border-bottom:3px double #000000; width:0pt;">&#8203;</td>
            <td style="border-bottom:3px double #000000;padding:1.75pt 0pt 1.25pt 0pt; width:293.66pt;text-align:left;">
              <font style="letter-spacing:0.15pt;">Total </font>
            </td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:3px double #000000;padding:1.75pt 0pt 1.25pt 0pt; width:173.77pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.15pt;">$250,000,000</font><font style=" position:relative; bottom:3pt;font-size:5.5pt;letter-spacing:0.11pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:5.75pt;">&#8203;</td>
            <td style="width:0pt;padding:0pt;font-size:0pt;line-height:0pt;padding-left:0.75pt;background-color:#000000;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:5.75pt;">&#8203;</td>
            <td style="border-bottom:3px double #000000;padding:1.75pt 0pt 1.25pt 0pt; width:50.88pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.15pt;">$27,275.00</font><font style=" position:relative; bottom:3pt;font-size:5.5pt;letter-spacing:0.11pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:4.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.15pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4.31pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.15pt;">An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:2.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.15pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:2.8pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.15pt;">Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $250,000,000. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:2.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.15pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:2.8pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.15pt;">The registration fee has been calculated in accordance with Rule&#160;457(o) under the Securities Act of 1933, as amended. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:2.633pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 2.63333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:3.8pt; width:541.31pt; line-height:7.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.15pt;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act, or until this registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</font><font style="font-weight:normal;letter-spacing:0.15pt;"> </font>
        </div>
        <div style="margin-top:4.143pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 4.14333333333343pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.3pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 1.29999999999995pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="position:relative;overflow-x:hidden;min-height:775.71pt;page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="position:absolute;top:738.83pt;left:48.66pt;height:30.02pt;width:706pt;transform-origin:0pt -0pt;transform:rotate(-90deg) translate(0%, 0%);">
        <div style="text-align:justify; width:706pt; line-height:9.5pt;font-weight:bold;color:#FC0014;font-family:Helvetica, Arial, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.08pt;">The information contained in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where such offer or sale is not permitted. </font>
        </div>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:87.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
          <font style="letter-spacing:-0.2pt;">SUBJECT TO COMPLETION, DATED FEBRUARY 1, 2021</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:3pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="lg_annovis-4c.jpg" alt="[MISSING IMAGE: lg_annovis-4c.jpg]" height="118" width="234" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">$250,000,000</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:3pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Common Stock </font>
          <br >
          <font style="letter-spacing:-0.28pt;">Preferred Stock </font>
          <br >
          <font style="letter-spacing:-0.28pt;">Warrants </font>
          <br >
          <font style="letter-spacing:-0.28pt;">Units</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">We may offer and sell from time to time shares of common stock, shares of preferred stock, warrants, or any combination of those securities, either individually or in&#160;units, up to an aggregate initial offering price of $250,000,000, in one or more transactions under this prospectus. The securities may be offered in amounts, at prices and on terms to be determined based on market conditions at the time of sale and set forth in an accompanying prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus provides you with a general description of the securities that we may offer. Each time we offer securities, we will provide you with a prospectus supplement that describes specific information about the particular securities being offered and may add, update or change information contained or incorporated by reference in this prospectus. You should read both this prospectus and the applicable prospectus supplement, together with the additional information that is incorporated by reference into this prospectus and the applicable prospectus supplement, before you invest in any of our securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">The securities may be sold by us to or through underwriters or dealers, directly to purchasers or through agents designated from time to time, or through a combination of these methods. For additional information on the methods of sale, you should refer to the section entitled &#8220;Plan of Distribution&#8221; in this prospectus and the comparable section of any applicable prospectus supplement. If any underwriters are involved in the sale of the securities with respect to which this prospectus is being delivered, the names of such underwriters and any applicable discounts or commissions and options will be set forth in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:10.5pt;">
          <font style="letter-spacing:0.2pt;">Our common stock is listed on the NYSE American under the ticker symbol &#8220;ANVS.&#8221; On January&#160;29, 2021, the last reported sale price per share of our common stock on the NYSE American was $9.98 per share. We have not yet determined whether the other securities that may be offered by this prospectus will be listed on any exchange, interdealer quotation system or over-the-counter market. If we decide to seek the listing of any such securities upon issuance, the prospectus supplement relating to those securities will disclose the exchange, quotation system or market on which those securities will be listed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:9pt; width:456pt; line-height:10.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. RISKS ASSOCIATED WITH AN INVESTMENT IN OUR SECURITIES WILL BE DESCRIBED IN THE APPLICABLE PROSPECTUS SUPPLEMENT AND CERTAIN OF OUR FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION INCORPORATED BY REFERENCE INTO THIS PROSPECTUS, AS DESCRIBED UNDER &#8220;RISK FACTORS&#8221; ON PAGE 5.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:9pt; width:456pt; line-height:10.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You should read this prospectus and any applicable prospectus supplement together with additional information described under the heading &#8220;Where You Can Find Additional Information&#8221; before you make your investment decision.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:9pt; width:456pt; line-height:10.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:22.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:21pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The date of this prospectus is February&#160;1, 2021.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:375.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:215.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:420pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tATP"><font style="letter-spacing:0.2pt;">ABOUT THIS PROSPECTUS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tATP">1 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tFOST"><font style="letter-spacing:0.2pt;">FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tFOST">2 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTHCO"><font style="letter-spacing:0.2pt;">THE COMPANY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tTHCO">3 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tRIFA">4 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tUOP">5 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tGDOO"><font style="letter-spacing:0.2pt;">GENERAL DESCRIPTION OF OUR SECURITIES </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tGDOO">6 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOOC"><font style="letter-spacing:0.2pt;">DESCRIPTION OF OUR CAPITAL STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tDOOC">7 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOOW"><font style="letter-spacing:0.2pt;">DESCRIPTION OF OUR WARRANTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tDOOW">12 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOOU"><font style="letter-spacing:0.2pt;">DESCRIPTION OF OUR UNITS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tDOOU">13 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPOD"><font style="letter-spacing:0.2pt;">PLAN OF DISTRIBUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tPOD">14 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tLEMA">17 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:420pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tEXP">17 </a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:420pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION; INCORPORATION BY REFERENCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <a href="#tWYCF">17</a>
            </td>
            <td style="padding:0pt;padding-left:7pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tATP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:192pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As used in this prospectus, unless the context otherwise requires, the terms &#8220;Annovis,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Annovis Bio, Inc. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is a part of a registration statement that we filed with the Securities and Exchange Commission, (the &#8220;SEC&#8221;), using a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may offer to sell any of the securities, or any combination of the securities, described in this prospectus, in each case, in one or more offerings, up to an aggregate dollar amount of $250,000,000. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus provides you with a general description of the securities that we may offer. Each time securities are sold under this registration statement, we will provide an accompanying prospectus supplement that will contain specific information about the terms of those securities and the terms of that offering. The accompanying prospectus supplement may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and any accompanying prospectus supplement, you should rely on the information in the accompanying prospectus supplement. You should read both this prospectus and any accompanying prospectus supplement, including all documents incorporated by reference herein and therein, together with the additional information described under &#8220;Where You Can Find Additional Information&#8221; below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The information contained in this prospectus is not complete and may be changed. You should rely only on the information provided in or incorporated by reference in this prospectus or in any accompanying prospectus supplement, or documents to which we otherwise refer you. We have not authorized anyone else to provide you with different information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have not authorized any dealer, agent or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus and any accompanying prospectus supplement. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or an accompanying prospectus supplement. This prospectus and the accompanying prospectus supplement, if any, do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor do this prospectus and any accompanying prospectus supplement, if any, constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus and any accompanying prospectus supplement is accurate on any date subsequent to the date set forth on the front of such document or that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus and any accompanying prospectus supplement is delivered, or securities are sold on a later date. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tFOST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus, including documents incorporated by reference, any applicable prospectus supplement and any related free writing prospectus, contain forward-looking statements, as defined in Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;objective,&#8221; &#8220;ongoing,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; or &#8220;would,&#8221; and or the negative of these terms, or other comparable terminology intended to identify statements about the future. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The forward-looking statements in this prospectus include, among other things, statements about: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our business strategies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing of regulatory submissions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to obtain and maintain regulatory approval of our existing product candidates and any other product candidates we may develop, and the labeling under any approval we may obtain; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">risks relating to the timing and costs of clinical trials and the timing and costs of other expenses; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">risks related to market acceptance of products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">risks associated with our reliance on third-party organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our competitive position; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">assumptions regarding the size of the available market, product pricing and timing of commercialization of our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our intellectual property position and our ability to maintain and protect our intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our results of operations, financial condition, liquidity, prospects, and growth strategies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our cash needs and financing plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the industry in which we operate; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the trends that may affect the industry or us. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot guarantee that the results and other expectations expressed, anticipated or implied in any forward-looking statement will be realized. The risks set forth under Item&#160;1A of our Form 10-K for the year ended December&#160;31, 2019, as revised or supplemented by our Quarterly Reports on Form 10-Q and other documents we file with the SEC, describe material risks to our business, and you should read and interpret any forward-looking statements together with these risks. A variety of factors, including these risks, could cause our actual results and other expectations to differ materially from the anticipated results or other expectations expressed, anticipated or implied in our forward-looking statements. Should known or unknown risks materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected in the forward-looking statements. You should bear this in mind as you consider any forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You should read this prospectus, including documents incorporated by reference, any applicable prospectus supplement and any related free writing prospectus completely and with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements contained in this prospectus are made as of the date of this prospectus and we do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTHCO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:284pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">THE COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a clinical stage, drug platform company addressing neurodegeneration such as Alzheimer&#8217;s disease (&#8220;AD&#8221;), Parkinson&#8217;s disease (&#8220;PD&#8221;) and Alzheimer&#8217;s disease in Down Syndrome (&#8220;AD-DS&#8221;). Our lead compound, ANVS401, is a small molecule administered orally that attacks neurodegeneration by entering the brain and inhibiting the translation of neurotoxic proteins&#8201;&#8212;&#8201;amyloid precursor protein APP/A&beta; (&#8220;APP&#8221;), tau/phospho-tau (&#8220;tau&#8221;) and &alpha;-Synuclein (&#8220;&alpha;SYN&#8221;)&#8201;&#8212;&#8201;thereby improving axonal transport. Human studies in four mildly cognitive impaired (&#8220;MCI&#8221;) patients have shown that ANVS401 lowered the levels of neurotoxic proteins and inflammatory factors. In preclinical studies, lower neurotoxic protein levels led to improved axonal transport, reduced inflammation, lower nerve cell death and improved function. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that ANVS401 has the potential to be the first drug to interfere with the underlying mechanism of neurodegeneration. ANVS401 is a small, once a day, orally administered, brain penetrant inhibitor of neurotoxic proteins. The biological activity of ANVS401 has been evaluated in 20 animal studies conducted in leading institutions such as the Karolinska Institute, Columbia University and Harvard University. 18 of the studies are published and two are presently manuscripts in preparation. We also conducted three clinical trials with 125 humans including two safety studies in 120 healthy volunteers and a proof-of-concept study in four MCI patients with Parexel, an international clinical research organization. In these studies, we showed that ANVS401 was well tolerated and we saw promising clinical signals: in all four patients, ANVS401 reduced the levels of APP, tau and &alpha;SYN (&alpha;SYN is an unpublished, not statistically significant observation) and lowered inflammatory factors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are presently conducting a Phase&#160;2a clinical trial in 24 AD patients in collaboration with the Alzheimer&#8217;s Disease Cooperative Study (&#8220;ADCS&#8221;) and a second Phase&#160;2a clinical trial of ANVS401 with 14 AD patients and 54 PD patients (the &#8220;AD/PD Trial&#8221;), which began treating patients in August&#160;2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We were incorporated under the laws of the State of Delaware in 2008. Our principal executive offices are located at 1055 Westlakes Drive, Suite 300, Berwyn, PA 19312. Our telephone number is 610-727-3913. Our website address is www.annovisbio.com. The information contained in, or accessible through, our website does not constitute a part of this prospectus. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:464pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investing in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risk. The prospectus supplement applicable to each offering of our securities will contain a discussion of the risks applicable to an investment in any such securities. Prior to making a decision about investing in any securities offered, you should carefully consider the specific factors discussed under the heading &#8220;Risk Factors&#8221; in the applicable prospectus supplement, together with all of the other information contained or incorporated by reference in the prospectus supplement or appearing or incorporated by reference in this prospectus. You should also consider the risks, uncertainties and assumptions discussed under the heading &#8220;Risk Factors&#8221; in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents that we file with the SEC, which are incorporated herein by reference as described in this prospectus under the heading &#8220;Where You Can Find Additional Information&#8221;. The risks and uncertainties we have described in such documents are not the only risks that we face. Additional risks and uncertainties not presently known to us may also affect our operations. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:536pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in the applicable prospectus supplement relating to a specific offering, we&#160;intend to use the net proceeds from the sale of securities by us under this prospectus and any applicable prospectus supplement for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures, clinical trial expenditures, acquisitions of new technologies, products or businesses, and investments. Pending these uses, we expect to invest the net proceeds in short-term, investment-grade securities. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tGDOO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:366pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">GENERAL DESCRIPTION OF OUR SECURITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may offer and sell, at any time and from time to time: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">shares of our common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">shares of our preferred stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">warrants to purchase common shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">units consisting of a combination of the foregoing securities; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any combination of these securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains summary descriptions of the common stock, preferred stock, warrants, and&#160;units that we may offer and sell from time to time. When particular securities are offered by us, a supplement to this prospectus will describe the terms of the securities and the extent to which these general descriptions may apply. These summary descriptions and any summary descriptions in the applicable prospectus supplement are not complete descriptions of the terms and conditions of each security and are qualified in their entirety by reference to our amended and restated certificate of incorporation and our amended and restated bylaws which are incorporated by reference in the registration statement of which this prospectus is a part. Please refer to &#8220;Where You Can Find Additional Information&#8221; below for directions on obtaining these documents. If any particular terms of a security described in the applicable prospectus supplement differ from any of the terms described in this prospectus, then the terms described in this prospectus will be deemed superseded by the terms set forth in that prospectus supplement. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF OUR CAPITAL STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Authorized and Outstanding Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our authorized share capital consists of 37,000,000 shares of capital stock, each with a par value of $0.0001 per share. Of these shares, 35,000,000 shall be common stock and 2,000,000 shall be preferred stock. As of January&#160;29, 2021, there were 6,906,137 shares of common stock outstanding and no shares of preferred stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The holders of our common stock are entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. There is no cumulative voting. An election of directors by our stockholders shall be determined by a plurality of the votes cast by stockholders entitled to vote in the election. Subject to the supermajority votes for some matters, other matters shall be decided by the affirmative vote of our stockholders having a majority in voting power of the votes cast by the stockholders present or represented and voting on such matter. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the rights of holders of all classes of our stock outstanding having rights that are senior to or equivalent to holders of common stock, the holders of the common stock are entitled to receive proportionately any dividends when and as declared by our board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of our liquidation, dissolution or winding up, the holders of common stock are entitled to receive on a pro&#160;rata basis our net assets available for distribution to stockholders after the payment of all debts and other liabilities, subject to the rights of holders of all classes of our stock outstanding having rights that are senior to or equivalent to holders of common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Holders of common stock have no preemptive, subscription, redemption or conversion rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All of our outstanding shares of common stock are fully paid and nonassessable, and any shares of common stock to be issued upon an offering pursuant to this prospectus and the related prospectus supplement will be fully paid and nonassessable upon issuance. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of our amended and restated certificate of incorporation, our board of directors is authorized to direct us to issue shares of preferred stock in one or more series without stockholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will fix the designations, powers, preferences and rights of the preferred stock of each series, as well as the qualifications, limitations or restrictions thereon, in the certificate of designation relating to that series. The applicable prospectus supplement will contain the terms of and other information relating to the preferred stock which will include, as applicable: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the title and stated value; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of shares we are offering; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the liquidation preference per share; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the purchase price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:4pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the dividend rate, period and payment date and method of calculation for dividends; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the procedures for any auction and remarketing, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the provisions for a sinking fund, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any listing of the preferred stock on any securities exchange or market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether the preferred stock will be convertible into our common stock, and, if applicable, the conversion price, or how it will be calculated, and the conversion period; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">voting rights, if any, of the preferred stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">preemptive rights, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">restrictions on transfer, sale or other assignment, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether interests in the preferred stock will be represented by depositary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a discussion of any material United States federal income tax considerations applicable to the preferred stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors may authorize the issuance of preferred stock with voting, conversion or other rights that could adversely affect the voting power or other rights of the holders of our common stock. Preferred stock could be issued quickly with terms designed to delay or prevent a change in control of our company or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Registration Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under our registration rights agreement dated as of December&#160;19, 2014, the holders of approximately 2,273,847 shares of common stock, or their transferees, have the right to require us to register their shares under the Securities Act so that those shares may be publicly resold, or to include their shares in any registration statement we file, in each case as further described below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Demand Registration Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Commencing on July&#160;29, 2020, if holders of more than 50% of the securities registerable under the registration rights agreement request us to file a registration statement under the Securities Act for a public offering of such shares of registrable securities having an aggregate offering price of at least $10,000,000, we must, within ten days after the receipt of such notice, notify all holders of registrable securities of such request and shall use its reasonably diligent efforts to register under the Securities Act the registrable securities of all holders who so request within 90&#160;days after the date of our notice; provided, however, that we are obligated to register only shares of common stock pursuant to the agreement. We are obligated to effect a maximum of two such demand registrations. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Piggyback/Incidental Registration Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Whenever we propose to register any common stock for our own or others&#8217; account under the Securities Act for a public offering for cash, other than a registration relating to employee benefit plans, we must give each holder of registrable securities prompt written notice of its intent to do so. Upon the written request of any such holder given within 10&#160;days after receipt of such notice, we will cause to be included in such registration all of the registrable securities that such holder requests; provided, however, that we are obligated to register only shares of our common stock pursuant to the agreement. If we are advised in writing by any managing underwriter of the securities being offered pursuant to any registration statement that the number of shares to be sold by persons other than us is greater than the number of such shares that can be offered without adversely affecting the offering, we may reduce pro&#160;rata the number of shares of registrable securities offered for the accounts of such persons to a number deemed satisfactory by such managing underwriter; and a managing underwriter will have the right to exclude registrable securities entirely pursuant to the preceding clause. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Form S-3 Registration Rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If, at a time when Form S-3 (or any successor thereto) is available for such registration, we receive from holders of more than 15% of the registrable securities a written request or requests that we effect a registration on Form S-3 of registrable securities having an aggregate offering price of at least $5,000,000 (based on the then current public market price), we will promptly give written notice of the proposed registration to all other holders of registrable securities and, as soon as reasonably practicable, effect such registration and all such related qualifications and compliances as may be requested and as would permit the sale and distribution of all registrable securities as are specified in such request and any written requests of other holders given within 10&#160;days after receipt of such notice; provided, however, that the Company shall not be obligated to effect any such registration pursuant to the agreement: (i)&#160;if Form S-3 is not available for such offering by the applicable holders; or (ii)&#160;if we furnish to the applicable holders a certificate signed by the chief executive officer stating that in the good faith judgment of the board of directors, it would be seriously detrimental to us and our stockholders for such Form S-3 registration to be effected at such time, in which event we will have the right to defer the filing of the Form S-3 registration statement for a period of not more than 120&#160;days after receipt of the request of the holder or holders; provided, however, that we may not utilize this right more than twice in any 12-month period. We are not obligated to file more than two registrations under this provision. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Provisions and Expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A registrable security will cease to be a registrable security when (i)&#160;a registration statement covering such registrable security has been declared effective by the SEC and it has been disposed of pursuant to such effective registration statement; or (ii)&#160;such registrable security could be sold pursuant to Rule&#160;144 (or any successor or comparable provision) without any volume restriction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other than underwriting discounts and commissions and certain other expenses, we will be required to pay all expenses incurred by us related to any registration effected pursuant to the exercise of these registration rights. These expenses may include all registration and filing fees, printing expenses, fees and disbursements of our counsel, reasonable fees and disbursements of a counsel for the selling securityholders and blue-sky fees and expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Some provisions of Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws could make the following transactions more difficult: an acquisition of us by means of a tender offer; an acquisition of us by means of a proxy contest or otherwise; or the removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions which provide for payment of a premium over the market price for our shares. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These provisions, summarized below, are intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of the increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Authorized but Unissued Shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital and corporate acquisitions. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of a majority of our common stock by means of a proxy contest, tender offer, merger or otherwise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Meetings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Requirements for Advance Notification of Stockholder Nominations and Proposals</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#8217;s notice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Delaware Anti-Takeover Statute</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to Section&#160;203 of the General Corporation Law of the State of Delaware, which prohibits persons deemed to be &#8220;interested stockholders&#8221; from engaging in a &#8220;business combination&#8221; with a publicly held Delaware corporation for three&#160;years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three&#160;years prior to the determination of interested stockholder status did own, 15% or more of a corporation&#8217;s voting stock. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Choice of Forum</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Court of Chancery of the State of Delaware is the exclusive forum in which we and our directors may be sued by our stockholders, to the fullest extent permitted by law, for: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any derivative action or proceeding brought on our behalf; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any action asserting a breach of fiduciary duty; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation, or our amended and restated bylaws; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">or any action asserting a claim against us that is governed by the internal affairs doctrine. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated bylaws will not apply to suits brought to enforce a duty or liability created by the Securities Act or the Exchange Act, or any other claim for which federal courts have exclusive jurisdiction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These choice of forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:304pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">discourage lawsuits with respect to such claims. Alternatively, if a court were to find either choice of forum provision contained in our amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Advance Notice Requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors. Stockholders at an annual meeting will only be able to consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given our Secretary timely written notice, in proper form, of the stockholder&#8217;s intention to bring that business before the meeting. Although our bylaws do not give the board of directors the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted at a special or annual meeting, our bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The NYSE American</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our common stock is listed on the NYSE American under the symbol &#8220;ANVS.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for our common stock is American Stock Transfer &amp; Trust Company,&#160;LLC.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOOW">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:26pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF OUR WARRANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue warrants to purchase our common stock and/or preferred stock in one or more series. We may issue warrants independently or together with common stock and/or preferred stock, and the warrants may be attached to or separate from these securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The terms of each series of warrants will be contained in the applicable warrant agreements. The applicable prospectus supplement for the warrants will contain the terms of and other information relating to the warrants which will include, as applicable: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the offering price and aggregate number of warrants offered; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the currency in which the offering price, if any, and the exercise price are payable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the date on and after which the warrants and the related securities will be separately transferable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in the case of warrants to purchase common stock or preferred stock, the exercise price and the number of shares of common stock or preferred stock, as applicable, to be received upon exercise of the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the date on which the right to exercise the warrants will begin and the date on which that right will expire or, if the warrants may not be continuously exercised throughout that period, the specific date or dates on which the warrants may be exercised; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">a discussion of any material United States federal income tax considerations related to the holding or exercise of the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the identity of the warrant agent for the warrants, if any, and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the designation and terms of the securities issuable upon exercise of the warrants; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the minimum or maximum amount of the warrants that may be exercised at any one time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the anti-dilution provisions of the warrants, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rights to redeem or call the warrants, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any other specific terms, preferences, rights and limitations of or restrictions on the warrants. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before the exercise of their warrants, holders of warrants will not have any of the rights of holders of the securities issuable upon exercise. Holders of warrants to purchase common stock or preferred stock will not be entitled to vote, consent, receive dividends, receive notice as stockholders with respect to any meeting of stockholders for the election of our directors, receive payments upon our liquidation, dissolution or winding up, or to exercise any rights whatsoever as our stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for any warrants will be set forth in the applicable prospectus supplement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOOU">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF OUR UNITS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following description, together with the additional information we include in any applicable prospectus supplement, summarizes the material terms and provisions of the&#160;units that we may offer under this prospectus. Units may be offered independently or together with common stock, preferred stock or warrants offered by any prospectus supplement, and may be attached to or separate from those securities. While the terms we have summarized below will generally apply to any future&#160;units that we may offer under this prospectus, we will describe the particular terms of any series of&#160;units that we may </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">offer in more detail in the applicable prospectus supplement. The terms of any&#160;units offered under an applicable prospectus supplement may differ from the terms described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will incorporate by reference into the registration statement of which this prospectus forms a part the form of unit agreement, including a form of unit certificate, if any, that describes the terms of the series of&#160;units we are offering before the issuance of the related series of&#160;units. The following summaries of material provisions of the&#160;units, and the unit agreements, are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement applicable to a particular series of&#160;units. We urge you </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">to read the applicable prospectus supplements related to the&#160;units that we sell under this prospectus, as well as the complete unit agreements that contain the terms of the&#160;units. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may issue&#160;units comprised of one or more of the securities described in this prospectus in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement, if any, under which a unit is issued may provide that the securities comprising the unit may not be held or transferred separately, at any time or at any time before a specified date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The particular terms and provisions of&#160;units offered by an applicable prospectus supplement, and the extent to which the general terms and provisions described below may apply thereto, will be described in the applicable prospectus supplement filed in respect of such&#160;units. This description will include, where applicable: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the designation and aggregate number of&#160;units offered; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the price at which the&#160;units will be offered; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rights and obligations of the unit agent, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the currency or currencies in which the&#160;units are denominated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any provisions of the governing unit agreement that differ from those described below; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the terms of the&#160;units and of the securities comprising the&#160;units, including whether and under what circumstances those securities may be held or transferred separately; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the number of securities that may be purchased upon exercise of each unit and the price at which the currency or currencies in which that amount of securities may be purchased upon exercise of each unit; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any provisions for the issuance, payment, settlement, transfer, adjustment or exchange of the&#160;units or of the securities comprising the&#160;units; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any other material terms of the&#160;units. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We reserve the right to set forth in an applicable prospectus supplement specific terms of the&#160;units that are not within the options and parameters set forth in this prospectus. In addition, to the extent that any particular terms of the&#160;units described in an applicable prospectus supplement differ from any of the terms described in this prospectus, the description of such terms set forth in this prospectus shall be deemed to have been superseded by the description of the differing terms set forth in such prospectus supplement with respect to such&#160;units. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell the securities, from time to time, to or through underwriters or dealers, through agents or remarketing firms, or directly to one or more purchasers pursuant to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">underwritten public offerings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">negotiated transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">block trades; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">&#8220;At the Market Offerings,&#8221; within the meaning of Rule&#160;415(a)(4) of the Securities Act of 1933, as amended, or the Securities Act, into an existing trading market, at prevailing market prices; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">through a combination of these methods. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell the securities to or through one or more underwriters or dealers (acting as principal or agent), through agents, or directly to one or more purchasers. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may distribute securities from time to time in one or more transactions: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at a fixed price or prices, which may be changed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at market prices prevailing at the time of sale; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at prices related to such prevailing market prices; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">at negotiated prices. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of the securities, including, to the extent applicable: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the name or names of the underwriters, dealers or agents, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if the securities are to be offered through the selling efforts of brokers or dealers, the plan of distribution and the terms of any agreement, arrangement, or understanding entered into with broker(s) or dealer(s) prior to the effective date of the registration statement, and, if known, the identity of any broker(s) or dealer(s) who will participate in the offering and the amount to be offered through each; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the purchase price of the securities or other consideration therefor, and the proceeds, if any, we will receive from the sale; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">if any of the securities being registered are to be offered otherwise than for cash, the general purposes of the distribution, the basis upon which the securities are to be offered, the amount of compensation and other expenses of distribution, and by whom they are to be borne; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any delayed delivery arrangements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any over-allotment or other options under which underwriters may purchase additional securities from us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any agency fees or underwriting discounts and other items constituting agents&#8217; or underwriters&#8217; compensation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any public offering price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any discounts, commissions or concessions allowed or reallowed or paid to dealers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the identity and relationships of any finders, if applicable; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">any securities exchange or market on which the securities may be listed. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In compliance with the guidelines of FINRA, the maximum compensation to the underwriters or dealers in connection with the sale by the Company of its securities pursuant to this prospectus and the accompanying supplement to this prospectus may not exceed 8% of the aggregate offering price of the securities as set forth on the cover page of any prospectus supplement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Only underwriters named in the prospectus supplement will be underwriters of the securities offered by the prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If underwriters are used in the sale, they will acquire the securities for their own account and may resell the securities from time to time in one or more transactions at a fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Unless otherwise indicated in the prospectus supplement, subject to certain conditions, the underwriters will be obligated to purchase all of the securities offered by the prospectus supplement, other than securities covered by any underwriter&#8217;s option. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers may change from time to time. We may use underwriters, dealers or agents with whom we have a material relationship. We will describe in the prospectus supplement, naming the underwriter, dealer or agent, the nature of any such relationship. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may use a remarketing firm to offer the securities in connection with a remarketing arrangement upon their purchase. Remarketing firms will act as principals for their own account or as agents for us. These remarketing firms will offer or sell the securities pursuant to the terms of the securities. A prospectus supplement will identify any remarketing firm and the terms of its agreement, if any, with us and will describe the remarketing firm&#8217;s compensation. Remarketing firms may be deemed to be underwriters in connection the securities they remarket. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we offer and sell securities through a dealer, we or an underwriter will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. The name of the dealer and the terms of the transaction will be set forth in the applicable prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions payable to the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, the agent will act on a best-efforts basis for the period of its appointment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Dealers and agents participating in the distribution of the securities may be deemed to be underwriters, and compensation received by them on resale of the securities may be deemed to be underwriting discounts. If such dealers or agents were deemed to be underwriters, they may be subject to statutory liabilities under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may sell securities directly to one or more purchasers without using underwriters or agents. Underwriters, dealers and agents that participate in the distribution of the securities may be underwriters as defined in the Securities Act, and any discounts or commissions they receive from us and any profit on their resale of the securities may be treated as underwriting discounts and commissions under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may authorize agents or underwriters to solicit offers by certain types of institutional investors to purchase securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in the prospectus supplement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may provide agents, underwriters and dealers with indemnification against civil liabilities, including liabilities under the Securities Act, or contribution with respect to payments that the agents, underwriters or dealers may make with respect to these liabilities. Agents, underwriters and dealers, or their respective affiliates, may engage in transactions with, or perform services for, us in the ordinary course of business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The securities we offer may be new issues of securities and may have no established trading market. The securities may or may not be listed on a securities exchange. Underwriters may make a market in these securities but will not be obligated to do so and may discontinue any market making at any time without notice. We can make no assurance as to the liquidity of, or the existence of trading markets for, any of the securities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:368pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation&#160;M under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Over-allotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering or other short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any underwriters that are qualified market makers on the NYSE American may engage in passive market making transactions in the common stock on the NYSE American in accordance with Regulation&#160;M under the Exchange Act, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the common stock. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive market maker&#8217;s bid, however, the passive market maker&#8217;s bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise specified in a prospectus supplement, certain legal matters relating to the securities will be passed upon for us by Duane Morris LLP. As appropriate, legal counsel representing the underwriters, dealers or agents will be named in the accompanying prospectus supplement and may opine to certain legal matters. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The financial statements of Annovis Bio, Inc. as of December&#160;31, 2019 and 2018 and for the&#160;years then ended have been incorporated by reference herein in reliance upon the report of WithumSmith+Brown, PC, independent registered public accounting firm, incorporated by reference herein, upon the authority of said firm as experts in accounting and auditing. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION; </font>
          <br >
          <font style="letter-spacing:-0.2pt;">INCORPORATION BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Available Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet website at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Our reports on Forms 10-K, 10-Q and 8-K, and amendments to those reports, are also available for download, free of charge, as soon as reasonably practicable after these reports are filed with, or furnished to, the SEC, at our website at www.annovisbio.com. Information contained on or accessible through our website is not a part of this prospectus or any prospectus supplement, and the inclusion of our website address in this prospectus is an inactive textual reference only. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Incorporation by Reference</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows us to &#8220;incorporate by reference&#8221; into this prospectus the information in other documents that we file with it. This means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information in documents that we file later with the SEC will automatically update and supersede information contained in documents filed earlier with the SEC or contained in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We incorporate by reference in this prospectus the documents listed below and any future filings that we may make with the SEC under Sections&#160;13(a), 13(c), 14, or 15(d) of the Exchange Act in this prospectus, between the date of this prospectus and the termination of the offering of the securities described in this prospectus. We are not, however, incorporating by reference any documents, information or portions thereof deemed to have been furnished and not filed, including any information that we disclose under Items&#160;2.02 or 7.01 of any Current Report on Form 8-K or related exhibits furnished pursuant to Item&#160;9.01 of Form 8-K. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920038326/tm2013055d1_10k.htm"><font style="letter-spacing:0.2pt;">our Annual Report on Form 10-K for the year ended December&#160;31, 2019, filed with the SEC on </font><font style="letter-spacing:0.2pt;">March&#160;25, 2020;</font></a><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our Quarterly Reports on Form 10-Q for the quarters ended March&#160;31, 2020, June&#160;30, 2020 and September&#160;30, 2020, filed with the SEC on </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920056617/tm2016851-1_10q.htm"><font style="letter-spacing:0.2pt;">May&#160;5, 2020</font></a><font style="letter-spacing:0.2pt;">, </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000155837020008577/anvs-20200630x10q.htm"><font style="letter-spacing:0.2pt;">July&#160;29, 2020</font></a><font style="letter-spacing:0.2pt;"> and </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000155837020012511/anvs-20200930x10q.htm"><font style="letter-spacing:0.2pt;">November&#160;4, 2020</font></a><font style="letter-spacing:0.2pt;">, respectively; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our Current Reports on Form 8-K as filed with the SEC on </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920011925/tm206971d1_8k.htm"><font style="letter-spacing:0.2pt;">February&#160;6, 2020</font></a><font style="letter-spacing:0.2pt;">, </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920042855/tm2014902-1_8k.htm"><font style="letter-spacing:0.2pt;">April&#160;3, 2020</font></a><font style="letter-spacing:0.2pt;">, </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920070148/tm2021835-1_8k.htm"><font style="letter-spacing:0.2pt;">June&#160;5, </font><font style="letter-spacing:0.2pt;">2020</font></a><font style="letter-spacing:0.2pt;">, and </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920071084/tm2022100-1_8k.htm"><font style="letter-spacing:0.2pt;">June&#160;9, 2020</font></a><font style="letter-spacing:0.2pt;"> (except information included pursuant to Items&#160;2.02 or 7.01 and exhibits related to such items); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the information specifically incorporated by reference into our Annual Report on Form 10-K for the year ended December&#160;31, 2019 from our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920050820/tm2016103d2_def14a.htm"><font style="letter-spacing:0.2pt;">Definitive Proxy Statement on Schedule&#160;14A, filed with </font><font style="letter-spacing:0.2pt;">the SEC on April&#160;24, 2020</font></a><font style="letter-spacing:0.2pt;"> (other than the portions thereof that are furnished and not filed); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920007323/tm199635-12_8a12b.htm"><font style="letter-spacing:0.2pt;">the description of our capital stock contained in our registration statement on Form 8-A filed with </font><font style="letter-spacing:0.2pt;">the SEC on January&#160;28, 2020, including any amendment or report filed for purposes of updating such </font><font style="letter-spacing:0.2pt;">description.</font></a><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">You may request, orally or in writing, a copy of any or all of the documents incorporated herein by reference. These documents will be provided to you at no cost, by contacting: Annovis Bio, Inc., 1055 Westlakes Drive, Suite 300, Berwyn, Pennsylvania 19312. In addition, copies of any or all of the documents incorporated herein by reference may be accessed at our website at www.annovisbio.com. The information on such website is not incorporated by reference and is not a part of this prospectus.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.8pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.8pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="position:relative;margin-top:74.3pt; text-align:center; width:456pt;">
          <img src="lg_annovis-4c.jpg" alt="[MISSING IMAGE: lg_annovis-4c.jpg]" height="131" width="260" >
        </div>
        <div style="margin-top:76.6pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">$250,000,000</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:71.42pt; text-align:center; width:456pt; line-height:15.5pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Common Stock </font>
          <br >
          <font style="letter-spacing:-0.28pt;">Preferred Stock </font>
          <br >
          <font style="letter-spacing:-0.28pt;">Warrants </font>
          <br >
          <font style="letter-spacing:-0.28pt;">Units</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:80.587pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 80.5866666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:11.8pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:10.633pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 10.6333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:87.8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">February&#160;1, 2021</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:83.15pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 83.15pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.81pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.80999999999995pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN THE PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;14. Other Expenses of Issuance and Distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the estimated costs and expenses, other than underwriting discounts and commissions, payable by the registrant in connection with the offering of the securities being registered. All the amounts shown are estimates, except for the Securities and Exchange Commission (the &#8220;SEC&#8221;) registration fee and Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) filing fee. The amounts do not include the costs of preparing any prospectus supplements, NYSE American listing fees, additional FINRA filing fees, transfer agent fees or other expenses relating to the sale and distribution of particular securities registered under this registration statement, as those costs and expenses cannot be estimated at this time. </font>
        </div>
        <table style="width:416pt;height:123pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:368.76pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">be paid </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:368.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC registration fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">27,275</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:368.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">FINRA filing fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-size:7.5pt;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-size:7.5pt;">
                <font style="position:relative;font-size:10pt;">&#8199;</font><font style="position:absolute;"><font style="font-size:10pt;"></font><font style=" position:relative; bottom:4.25pt;">(1)</font>
                </font>
              </div>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:368.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printing expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-size:7.5pt;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-size:7.5pt;">
                <font style="position:relative;font-size:10pt;">&#8199;</font><font style="position:absolute;"><font style="font-size:10pt;"></font><font style=" position:relative; bottom:4.25pt;">(1)</font>
                </font>
              </div>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:368.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-size:7.5pt;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-size:7.5pt;">
                <font style="position:relative;font-size:10pt;">&#8199;</font><font style="position:absolute;"><font style="font-size:10pt;"></font><font style=" position:relative; bottom:4.25pt;">(1)</font>
                </font>
              </div>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.99999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:368.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">
              <div style="font-size:7.5pt;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-size:7.5pt;">
                <font style="position:relative;font-size:10pt;">&#8199;</font><font style="position:absolute;"><font style="font-size:10pt;"></font><font style=" position:relative; bottom:4.25pt;">(1)</font>
                </font>
              </div>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:368.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">
              <div style="font-size:7.5pt;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-size:7.5pt;">
                <font style="position:relative;font-size:10pt;">&#8199;</font><font style="position:absolute;"><font style="font-size:10pt;"></font><font style=" position:relative; bottom:4.25pt;">(1)</font>
                </font>
              </div>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:368.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">
              <font style="position:relative;">&#8199;</font><font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(1)</font></font>
            </td>
            <td style="padding:0pt;padding-left:1.265pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.31pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">These fees and expenses depend on the securities offered and the number of issuances and, accordingly, cannot be estimated at this time. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;15. Indemnification of Directors and Officers.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;102 of the General Corporation Law of the State of Delaware permits a corporation to eliminate the personal liability of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our amended and restated certificate of incorporation provides that no director of ours shall be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the General Corporation Law of the State of Delaware prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145 of the General Corporation Law of the State of Delaware provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation, or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:136pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our amended and restated certificate of incorporation provides that we will indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an &#8220;Indemnitee&#8221;), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. Our amended and restated certificate of incorporation provides that we will indemnify any Indemnitee who was or is a party to an action or suit by or in the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys&#8217; fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have provided contractual indemnification rights to each of our directors and officers. These indemnification rights may require us, among other things, to indemnify our directors and officers for some expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as one of our directors or officers, or any of our subsidiaries or any other company or enterprise to which the person provides services at our request. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We maintain an insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In any underwriting agreement we enter into in connection with the sale of common stock being registered hereby, the underwriters will agree to indemnify, under certain conditions, us, our directors, our officers and persons who control us within the meaning of the Securities Act of 1933, as amended, against certain liabilities. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;16. Exhibits.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:203.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:29pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exhibit</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:415pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Description of Exhibit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;1.1* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:415pt;">
              <font style="letter-spacing:0.2pt;">Form of Underwriting Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;4.1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:415pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000104746919005362/a2239691zex-4_1.htm"><font style="letter-spacing:0.2pt;">Specimen Certificate evidencing shares of the Registrant&#8217;s Common Stock. (Incorporated by </font><font style="letter-spacing:0.2pt;">reference to Exhibit&#160;4.1 to Amendment No. 3 to Form S-1 filed September&#160;20, 2019)</font></a>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;4.2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:415pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1477845/000110465920038326/tm2013055d1_ex4-2.htm"><font style="letter-spacing:0.2pt;">Form of Warrant to purchase common stock issued to ThinkEquity, a division of Fordham </font><font style="letter-spacing:0.2pt;">Financial Management, Inc. (Incorporated by reference to Exhibit&#160;4.2 to Form 10-K filed </font><font style="letter-spacing:0.2pt;">March&#160;25, 2020)</font></a>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;4.3* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <font style="letter-spacing:0.2pt;">Form of Preferred Stock Certificate </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;4.4* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <font style="letter-spacing:0.2pt;">Form of Warrant Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;4.5* </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <font style="letter-spacing:0.2pt;">Form of Unit Agreement </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">&#8199;5.1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <a style="-sec-extract:exhibit" href="tm213941d2_ex5-1.htm"><font style="letter-spacing:0.2pt;">Opinion of Duane Morris LLP regarding the legality of the securities being registered </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">23.1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <a style="-sec-extract:exhibit" href="tm213941d2_ex23-1.htm"><font style="letter-spacing:0.2pt;">Consent of WithumSmith+Brown, PC</font></a>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">23.2 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <a style="-sec-extract:exhibit" href="tm213941d2_ex5-1.htm"><font style="letter-spacing:0.2pt;">Consent of Duane Morris LLP (included in Exhibit&#160;5.1) </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:29pt;">
              <font style="letter-spacing:0.2pt;">24.1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:415pt;">
              <a href="#tSIG"><font style="letter-spacing:0.2pt;">Power of Attorney (included in signature page to registration statement</font></a><font style="letter-spacing:0.2pt;">)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">To be filed, if necessary, subsequent to the effectiveness of this registration statement by an amendment to this registration statement or incorporated by reference pursuant to a Current Report on Form 8-K in connection with an offering of securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;17. Undertakings.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(1)&nbsp;&nbsp;&nbsp;To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To include any prospectus required by section 10(a)(3) of the Securities Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that paragraphs (i), (ii)&#160;and (iii)&#160;do not apply if the registration statement is on Form S-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference in the registration statement or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(3)&nbsp;&nbsp;&nbsp;To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; </font>
        </div>
        <div style="text-indent:40pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4)&nbsp;&nbsp;&nbsp;That, for the purpose of determining liability under the Securities Act to any purchaser: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(5)&nbsp;&nbsp;&nbsp;That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </font>
        </div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) of the Exchange Act that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(h)&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:500pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(j)&nbsp;&nbsp;&nbsp;If and when applicable, the undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a)&#160;of Section&#160;310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Securities and Exchange Commission under Section&#160;305(b)(2) of the Act.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSIG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:22.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Berwyn, Commonwealth of Pennsylvania, on this 1st day of February&#160;2021. </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:0.2pt;">ANNOVIS BIO, INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:208.81pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 1pt 0pt; width:14.38pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 1pt 0pt; width:208.81pt;white-space:normal;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ MARIA MACCECCHINI</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 208.81pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Maria Maccecchini </font>
                <br >
                <font style="letter-spacing:0.2pt;">President and Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">KNOW ALL BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Maria Maccecchini and Jeffrey McGroarty, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution, for him or her and in his or her name, place or stead in any and all capacities, to sign any and all amendments including post-effective amendments to this registration statement, and any other registration statements for the same offering pursuant to Rule&#160;462(b) of the Securities Act of 1933, as amended, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </font>
        </div>
        <table style="width:456pt;height:244.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;min-height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:163pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:77pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:24pt;white-space:normal;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 7.333pt 0pt; width:163pt;text-align:center;vertical-align:top;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ </font><font style="text-transform:uppercase;letter-spacing:0.2pt;">M<font style="font-size:7pt;">aria</font> M<font style="font-size:7pt;">accecchini</font></font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 163pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Maria Maccecchini </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 7.333pt 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">President and Chief Executive Officer (principal executive officer) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:18.917pt 0pt 7.333pt 0pt; width:77pt;white-space:nowrap;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:24pt;white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:6.667pt 0pt 7.333pt 0pt; width:163pt;white-space:normal;text-align:center;vertical-align:top;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ </font><font style="text-transform:uppercase;letter-spacing:0.2pt;">J<font style="font-size:7pt;">effrey</font> M<font style="font-size:7pt;">c</font>G<font style="font-size:7pt;">roarty</font></font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 163pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Jeffrey McGroarty </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
              <br >
              <font style="letter-spacing:0.2pt;">(principal financial and accounting officer) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:77pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:12pt;white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:6.667pt 0pt 7.333pt 0pt; width:163pt;white-space:normal;text-align:center;vertical-align:top;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ MICHAEL HOFFMAN</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 163pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Michael Hoffman </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Chairman of the Board and Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:77pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:12pt;white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:6.667pt 0pt 7.333pt 0pt; width:163pt;white-space:normal;text-align:center;vertical-align:top;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ CLAUDINE BRUCK</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 163pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Claudine Bruck </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:77pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:12pt;white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:6.667pt 0pt 7.333pt 0pt; width:163pt;white-space:normal;text-align:center;vertical-align:top;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ ROBERT WHELAN</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 163pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Robert Whelan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:77pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;height:12pt;white-space:nowrap;text-align:left;vertical-align:middle;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:6.667pt 0pt 7.333pt 0pt; width:163pt;white-space:normal;text-align:center;vertical-align:top;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ MARK WHITE</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 163pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Mark White </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:192pt;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1px 0pt; width:77pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">February&#160;1, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm213941d2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NEW YORK<BR>
LONDON<BR>
SINGAPORE<BR>
PHILADELPHIA<BR>
CHICAGO<BR>
WASHINGTON, DC<BR>
SAN FRANCISCO<BR>
SILICON VALLEY<BR>
SAN DIEGO<BR>
SHANGHAI<BR>
TAIWAN<BR>
BOSTON<BR>
HOUSTON<BR>
LOS ANGELES<BR>
HANOI<BR>
HO CHI MINH CITY<I>&nbsp;</I></P></TD>
    <TD STYLE="width: 60%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I><IMG SRC="tm213941d2_ex5-1img001.jpg" ALT="dm_logo" STYLE="height: 36px; width: 195px"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>FIRM and AFFILIATE OFFICES</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>www.duanemorris.com</I></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ATLANTA<BR>
        BALTIMORE<BR>
        WILMINGTON<BR>
        MIAMI<BR>
        BOCA RATON<BR>
        PITTSBURGH<BR>
        NEWARK<BR>
        LAS VEGAS<BR>
        CHERRY HILL<BR>
        LAKE TAHOE<BR>
        MYANMAR</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ALLIANCES IN MEXICO<BR>
        AND SRI LANKA</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February&nbsp;1, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Annovis Bio,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">1055 Westlakes Drive, Suite&nbsp;300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Berwyn, PA 1931</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Re:</B></FONT></TD><TD><B><U>Exhibit&nbsp;5.1 to Registration Statement on Form&nbsp;S-3</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are acting as counsel
to Annovis Bio,&nbsp;Inc., a Delaware corporation (the &ldquo;Corporation&rdquo;), in connection with the preparation of a Registration
Statement on Form&nbsp;S-3 (the &ldquo;Registration Statement&rdquo;), under the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), and the filing thereof with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;). The Registration
Statement, including the prospectus which forms a part of the Registration Statement (the &ldquo;Prospectus&rdquo;, and as may
be supplemented from time to time by one or more prospectus supplements (each, a &ldquo;Prospectus Supplement&rdquo;)), provides
for the registration by the Corporation of up to a maximum aggregate offering price of $250,000,000 of any combination of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">shares
of the Corporation&rsquo;s common stock, par value $0.0001 per share (the &ldquo;Common Stock&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">shares
of the Corporation&rsquo;s preferred stock, par value $0.0001 per share (the &ldquo;Preferred Stock&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">warrants
to purchase shares of the Common Stock and/or the Preferred Stock (the &ldquo;Warrants&rdquo;), that the Corporation may issue
under warrant agreements between the Corporation and a warrant agent to be selected by the Corporation, to be dated on or about
the date of the first issuance of the applicable Warrants thereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Units
comprised of one or more of the Common Stock, the Preferred Stock, and the Warrants (the &ldquo;Units,&rdquo; and together with
the Common Stock, the Preferred Stock and the Warrants, collectively, the &ldquo;Securities&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Duane Morris </FONT><FONT STYLE="font-size: 10pt; font-variant: small-caps">llp</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">30
SOUTH 17TH STREET&nbsp;&nbsp;&nbsp;&nbsp;PHILADELPHIA, PA 19103-4196</FONT></TD>
    <TD STYLE="text-align: right; font-size: 10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PHONE:
215.979.1000&nbsp;&nbsp;&nbsp;&nbsp;FAX: 215.979.1020</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm213941d2_ex5-1img002.jpg" ALT="DM-Name" STYLE="height: 23px; width: 149px"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February&nbsp;1, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;2</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation is
registering the Securities for offering and sale from time to time pursuant to Rule&nbsp;415 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of
rendering this opinion letter, we have examined originals or copies (certified or otherwise identified to our satisfaction)
of: (i)&nbsp;the Registration Statement, in the form filed and to be filed with the Commission, and the exhibits filed or to
be filed in connection therewith; (ii)&nbsp;the Amended and Restated Certificate of Incorporation of the Corporation, as
amended, filed with the Secretary of State of the State of Delaware on January&nbsp;30, 2020, as certified by the Secretary
of the Corporation (as amended, the &ldquo;Certificate of Incorporation&rdquo;); (iii)&nbsp;the Bylaws of the Corporation, as
certified by the Secretary of the Corporation (as amended, the &ldquo;Bylaws&rdquo;); and (iv)&nbsp;minutes of a meeting of the Board of Directors of the Corporation, as attested to by the Secretary of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also have examined
and relied upon the originals, or copies certified to our satisfaction, of such other records, documents, certificates and other
instruments as in our judgment are necessary or appropriate to enable us to render the opinions expressed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In rendering this opinion
letter, we have assumed (i)&nbsp;the genuineness and authenticity of all signatures on original documents, (ii)&nbsp; the legal
capacity of all natural persons, (iii)&nbsp;the authenticity of all documents submitted to us as originals, (iv)&nbsp;the conformity
to originals of all documents submitted to us as certified, conformed or other copies and the authenticity of the originals of
such documents, (v)&nbsp;the accuracy, completeness and authenticity of certificates of public officials, (vi)&nbsp;that all records
and other information made available to us by the Corporation on which we have relied are complete in all material respects, and
(vii)&nbsp;the due authorization, execution and delivery of all documents where authorization, execution and delivery are prerequisites
to the effectiveness of such documents. As to all questions of fact material to the opinions expressed herein, we have relied solely
upon the above-referenced certificates or comparable documents and have assumed that the statements of the Corporation contained
in the Registration Statement are true and correct as to all factual matters stated therein, have not performed or had performed
any independent research of public records and have assumed that certificates of or other comparable documents from public officials
dated prior to the date hereof remain accurate as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this
opinion letter, we have further assumed the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">with
respect to our opinion in paragraph 1 below, that at the time of issuance and sale of any of the Offered Common Stock (as defined
below), the Corporation has authorized and reserved and made available for issuance a sufficient number of shares of the Common
Stock, and that the consideration for the issuance and sale of the Offered Common Stock is cash in an amount that is not less than
the par value of the Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">with
respect to our opinion in paragraph 2 below, that at the time of issuance and sale of any Offered Preferred Stock (as defined below),
the Corporation has authorized and reserved and made available for issuance a sufficient number of shares of the Preferred Stock,
and that the consideration for the issuance and sale of the Offered Preferred Stock is cash in an amount that is not less than
the par value of the Preferred Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm213941d2_ex5-1img002.jpg" ALT="DM-Name" STYLE="height: 23px; width: 149px"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February&nbsp;1, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">with
respect to Securities being issued upon conversion of any convertible Offered Preferred Stock, that the applicable convertible
Offered Preferred Stock will be validly issued, fully paid and nonassessable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">with
respect to any Securities being issued upon exercise of any Offered Warrants (as defined below) or upon settlement of any Offered
Unit Securities (as defined below), that the applicable Offered Warrants or Offered Unit Securities will on their date of issuance
be valid and legally binding obligations of the Corporation, enforceable against the Corporation in accordance with their terms,
except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium, or other similar laws relating
to or affecting creditors&rsquo; rights generally and by general equitable principles, regardless of whether such enforceability
is considered in a proceeding at law or in equity; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">With
respect to the Warrants, that the laws of the State of Delaware will govern any warrant agreements with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We express our opinion
solely with respect to the federal laws of the United States and the laws of the State of Delaware. We base our opinion on these
laws as in effect on the date hereof, and we disclaim any undertaking to advise you of any subsequent changes in the facts stated
or assumed in the Registration Statement or any Prospectus Supplement or of any subsequent changes in applicable law. We are not
rendering any opinion as to compliance with any federal or state antifraud law, rule&nbsp;or regulation relating to securities,
or to the sale or issuance thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the basis of the
foregoing and in reliance thereon, and subject to the qualifications stated in this opinion, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">With
respect to the Common Stock offered under the Registration Statement (the &ldquo;Offered Common Stock&rdquo;), provided that: (a)&nbsp;the
Registration Statement has become effective under the Securities Act and the Prospectus and any Prospectus Supplement required
by applicable laws have been delivered as required by such laws; (b)&nbsp;the Corporation has duly authorized the issuance of the
Offered Common Stock by all necessary corporate action; (c)&nbsp;the issuance and sale of the Offered Common Stock does not violate
any applicable law, the Certificate of Incorporation or the Bylaws, does not result in a default under or breach of any agreement
or instrument binding upon the Corporation, and complies with any applicable requirement or restriction imposed by any court or
governmental body having jurisdiction over the Corporation; and (d)&nbsp;the certificates for the Offered Common Stock have been
duly executed by the Corporation, countersigned by the transfer agent therefor and duly delivered to the purchasers thereof against
payment therefor, then, and only then will the Offered Common Stock, when issued and sold as contemplated in the Registration Statement,
the Prospectus and any related Prospectus Supplement and in accordance with any applicable duly authorized, executed and delivered
purchase, underwriting or similar agreement, or upon conversion of any convertible Offered Preferred Stock, or upon exercise of
any Offered Warrants in accordance with their terms, or upon settlement of any Offered Unit Securities in accordance with their
terms, be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm213941d2_ex5-1img002.jpg" ALT="DM-Name" STYLE="height: 23px; width: 149px"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February&nbsp;1, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;4</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">With
respect to the Preferred Stock offered under the Registration Statement (the &ldquo;Offered Preferred Stock&rdquo;), provided that:
(a)&nbsp;the Registration Statement has become effective under the Securities Act and the Prospectus and any related Prospectus
Supplement required by applicable laws have been delivered as required by such laws; (b)&nbsp;the Corporation has duly authorized
the issuance of the Offered Preferred Stock by all necessary corporate action; (c)&nbsp;the issuance and sale of the Offered Preferred
Stock does not violate any applicable law, the Certificate of Incorporation or the Bylaws, does not result in a default under or
breach of any agreement or instrument binding upon the Corporation, and complies with any applicable requirement or restriction
imposed by any court or governmental body having jurisdiction over the Corporation; and (d)&nbsp;the certificates for the Offered
Preferred Stock have been duly executed by the Corporation, countersigned by the transfer agent therefor and duly delivered to
the purchasers thereof against payment therefor, then, and only then will the Offered Preferred Stock, when issued and sold as
contemplated in the Registration Statement, the Prospectus and any related Prospectus Supplement and in accordance with any applicable
duly authorized, executed and delivered purchase, underwriting or similar agreement, or upon exercise of any Offered Warrants in
accordance with their terms, or upon settlement of any Offered Unit Securities in accordance with their terms, be validly issued,
fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">With
respect to the Warrants offered under the Registration Statement (the &ldquo;Offered Warrants&rdquo;), provided that: (a)&nbsp;the
Registration Statement has become effective under the Securities Act and the Prospectus and any related Prospectus Supplement required
by applicable laws have been delivered as required by such laws; (b)&nbsp;the Corporation has duly authorized the issuance of the
Offered Warrants by all necessary corporate action; (c)&nbsp;the issuance and sale of the Offered Warrants does not violate any
applicable law, , the Certificate of Incorporation or the Bylaws, does not result in a default under or breach of any agreement
or instrument binding upon the Corporation, and complies with any applicable requirement or restriction imposed by any court or
governmental body having jurisdiction over the Corporation; and (d)&nbsp;the Offered Warrants have been duly executed and delivered
by the Corporation and authenticated by the warrant agent therefor pursuant to the applicable warrant agreement and duly delivered
to the purchasers thereof against payment therefor, then, and only then will the Offered Warrants, when issued and sold as contemplated
in the Registration Statement, the Prospectus and any related Prospectus Supplement and in accordance with any applicable duly
authorized, executed and delivered purchase, underwriting or similar agreement, or upon conversion of any convertible Offered Preferred
Stock in accordance with their terms, be valid and legally binding obligations of the Corporation, enforceable against the Corporation
in accordance with their terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium
or other similar laws relating to or affecting creditors&rsquo; rights generally and by general equitable principles, regardless
of whether such enforceability is considered in a proceeding at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm213941d2_ex5-1img002.jpg" ALT="DM-Name" STYLE="height: 23px; width: 149px"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February&nbsp;1, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;5</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">With
respect to the Units offered under the Registration Statement (the &ldquo;Offered Unit Securities&rdquo;), provided that: (a)&nbsp;the
Registration Statement has become effective under the Securities Act and the Prospectus and any related Prospectus Supplement required
by applicable laws have been delivered as required by such laws; (b)&nbsp;the Corporation has duly authorized the issuance of the
Offered Unit Securities by all necessary corporate action; (c)&nbsp;the issuance and sale of the Offered Unit Securities does not
violate any applicable law, the Certificate of Incorporation or Bylaws, does not result in a default under or breach of any agreement
or instrument binding upon the Corporation, and complies with any applicable requirement or restriction imposed by any court or
governmental body having jurisdiction over the Corporation; and (d)&nbsp;the Corporation has duly executed and delivered the Offered
Unit Securities against payment therefor, then, and only then will the Offered Unit Securities, when issued and sold as contemplated
in the Registration Statement, the Prospectus and any related Prospectus Supplement and in accordance with any applicable duly
authorized, executed and delivered purchase, underwriting or similar agreement, be valid and legally binding obligations of the
Corporation, enforceable against the Corporation in accordance with their terms, except as enforcement thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors&rsquo; rights generally
and by general equitable principles, regardless of whether such enforceability is considered in a proceeding at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion letter
is to be used only in connection with the offer and sale of the Securities while the Registration Statement is in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to
the filing of this opinion with the Commission as an exhibit to the Registration Statement in accordance with the requirements
of Item 601(b)(5)&nbsp;of Regulation S-K under the Securities Act and to the use of this firm&rsquo;s name therein and in the related
prospectus under the caption &ldquo;Legal Matters.&rdquo; In giving this consent, we do not thereby admit that we are within the
category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules&nbsp;and regulations of the
Commission promulgated thereunder. This opinion letter is expressed as of the date hereof unless otherwise expressly stated, and
we disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent
changes in applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Duane Morris LLP</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm213941d2_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation
by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 25, 2020, relating
to the financial statements of Annovis Bio, Inc. appearing in the entity&rsquo;s Annual Report on Form 10-K for the years ended
December 31, 2019 and 2018. We also consent to the reference to us under the caption &ldquo;Experts&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ WithumSmith+Brown, PC</FONT></TD>
<TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>East Brunswick, New Jersey</TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">February 1, 2021</FONT></TD>
<TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_annovis-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_annovis-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ Q &( P$1  (1 0,1 ?_$ ,H  0 " @(# 0$
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M]'>5;/)W3_ MX.C6MLJ>]=O7*)2O7[K]^[=E15G)NB2C%1@HQ6% ]?0/41_
M,P?H>[>=Y-!^-WF=R/(TD->:/M#6L/"IK)72[D1H545:*=O1XPD[2>-4GF_0
MX#UC4GIA_ OH.3MVKU_^1&4UWK=_U.B]E:GSAU.]6WI]Z2RGB\U<QX<]9MU3
MQ,-O-R5)?N3MXRN*S+_U$K2\39W0OCL[ZDO85V7O?5-22.!#JMJ=&6N\/$@$
MH&%(QY9A1VA5B&]![3*$_8(YN1TS+EOX(KS;?V)4^QGQSS/^:STSQ.*')_+.
MMYTU5*65<QL.+\:6IYDJ/>JJ+[TCM= _'1TV@BA^\_(S9DHY "_<#!56K02!
MS?XX)$D%+$HF00'H'4QA#+XZ3.OO7%3PB_QXOU'XEJ?YK_/]VY+^C\IZ/9M?
MN_.R<F\UW5<%83?L1],Z^.YQK42$K/=^[6RW7T46)1W2?3H/H9(M;;B/KT'_
M  P^F2_I&S^8_P#I7[4</9_-8ZNQG6_RYR[.WW)YD7]OU$OP,0V_XY<&=-0]
M"Y/RS=7VC>TWM^N6;U,5OS"7W'L-9H\Q4A#H ]&XB'J/K],JEI-Y?#<BW_=:
M_6_M^X[WH/YL>I1DH\S\FV)PKMEBY\X.GA"[CSV_X_VG378O@"YFU5H[?TFS
M:<VBF@*@MHF(L\Q6;&\(7_)]K:VU^*KB*J@?XIY7M*(=.X?0<HGI^9!5X8R_
MNO\ [E'[C]_Y4_- ]/VMW[>+S%AZ_HTY4XKMW'M9%B#[:RQK]R^TN]8U7W(U
M7;HXN<B..[L&NZ].7S7:9U_M6\K.P3G]VWSC\W]C&6ID#NM2J@@01Z-G:OH'
M7-.582X;B<9/<FFJ^5:5]A]J=/NL_2GJK9^=T\U_3-5FH\4K=F]'Y\(]]S&G
MPY%M;?\ [EJ)@3!^FG/_ ,L#>; N"'D/W#P>NR;F =.+AJ>9=$_?;54I(."P
M[]$ZJ N)FN&,95*O6U!%+HDZ(F9-8O\ 9KD4)T[;;%^YCSX[7;O78_/Q\=_L
MV'RYZEO2KR%ZC>779U.$,#G?'@_I-2MPC\V#2EPVK^YW\9MUE;<E*+]ZU*$J
M\4W_ (T<F-3\L=50NW=/SAI2NR9SL9*-?$1:V&J6!JDBK)5BTQJ2[DL;-QY7
M*9C%*HJBLBHFN@HJ@JFJ?L>-DPR8<<*[Z-/>GW/]-I_.;U?Z/\[]$.=LCD3G
MS&5G5;*4[=R#<K&38DVK>1C7'&/S+,^&23<8SA.,K=R$+L)PCV S9/RX8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@&NSR
M0<\ZQP;TPM--A836XKPC(1&IJ@X'WDU9-)$I7=LGFR:J2X5:L"NFHL "0SM<
MR38AB"H95+C\[,^GCP0H[TEL\%WO]7>_"I]6^DKTS:SZC^H,=/NJ[C\@Z;*%
MW4\J.QJVW[N-9DTU]3D<,HPJFK<%.])2X%"<$38>P[KMBZV38NP[%)6NYVZ4
M<3$_/2JWO/'SUR8!'J/0$T&R"92IHHI@1%!$A4TRE(4I0Z[VU;K)[6^]]Y_2
MQRKRKR]R1R[B<J<JXEG!Y?P+,;5BS;5(PA'[Y2DZRG.3<IR<I2;DVWW[X0>+
MCD'S15;6:/:IZVTZ1W[#W9UJ9N/8D@2,7[EO2X0!0>6ATF!NT52G18IG 2G<
M <HDRZQCWLF5+*7"GMD]R_:_!>UH^8O49ZS>EOI[A/1\J;U?GYVZPT_&E&MN
MM>&67>]Z./%[^%J5YJCC:<7Q$JWBOXIN(/%<L9,P]&)LS8[ R#D-D;238V68
M9R"/:<KJM0QFB-:JQFZ_<*"K1H#\A! IW*HAW9S=G3,>W[US^)/QW>R.[RK5
MKO/%#K3ZV>O'6EWM/S]2>C\I74X_0:<YX]J<'LX<B[Q/(R>)4XXW+OR6]L;,
M*T-DH  ?3^YG(T/D=NIS@P, 8 P!@'K)B%A[%&/82?BHV<AI-N=I)1,PQ:R<
M9(-50Z*MGS!ZDNT=MU ]#$4(8HA]0R$[<+D>"XE*+[&JK[#<P-1S]*S+>HZ7
M?O8VH69J5N[:G*W<A);I0G!J49+L<6FN\TY\I/"#Q0WF>2L>KV[WCS>G"*ZB
M7[C-VJ^NG\@<QE"*RE!<E*WCT^H@7MAW$8F ?F%-0WUXN]I5IUECMPEW/;']
MJ[MCHNX^^>C'YC'6[IO&UI/.<[?-7+<))/ZR4EG0@MC5O-C[TWVURH9$GN4H
MK=%CY;<%.0W#.RGBMLU)52K/'JS:L[)KY5I*C68A3'% &TJ5(IHR350()S,7
MI6[L@ (@0Q.AQXB[;NV)_+O+AE]S\GV_CWI'M)T,]2G2OU Z0LWD?.BM:MVU
M+(P+]+>9CO97BMU?S+:DZ*]:<[3JDY*7NG3C('[Z=[N O.G87!W;C:U0:CF;
MUM95F4=M'7YUS_96&$36])2.3,H5%E:X--4ZC%SZ=>ID5.Y)0X9;9O3Q[GS;
M>_M78UW?L?8_"J/FGU.^FWE7U'<BST745#&YNPXSGIV:E[]B\U_+N.E9XUYI
M1O6_*Y"DX19/DU]?*OM"C5'8U)E$9JHWBNQ-HKLHAZ$>1,RR1?,U#)C^=!<J
M2P%52. *)* 8AP Q1 .T6KL+UN-R#K&2K^GBMS/YC>:>6M9Y-YDS^4^8K,L?
M7=-R[N/?MO?"[:FX35=S556,ELE%J46TTS[#+#@1@# & , 8 P!@# & , 8
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M9NLI0GCK9&RV2H<[ >*XP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MOREJO(7.&J<EZW'AU72\Z]BW=]'*S<E!R5=O#*G%%]L6F9!RTZL, 8 P!@#
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MY4VN$N&QX;DWL#6D?)P%1K]+9(U& U[J2?C&)HFMLF+!5PE*6Q\<RYB"J<%
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M^H!Z=.F9HB/'/O9L$XS?)%\NW&B68+(\H9O>%8:BD1S2>0T>TV?%/FR9D^J
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MH**%5<),US$*8J2@ED54=*G;7@]SZY1>/#<\1N[B]LJ5I4^U6;)6:LK+.'U
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M&,5%%-(@>@!EB-67O2+ACP]<'6'CT\>7'7C@K&-&-^CJDA>=TND$T??D]T;
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M&OQ[5X/554(2N:\BS( HHFV<!6HY%PZ(0PE%ZX6, CW"(S2H:TY<4J]A9O\
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M+RT-)"/=-GS!]Q4T>\8O6:Z3IH\:.I"^+MG35RB8Z+ANX14 Y#D$2G*(" B
MXCN]I7>^)>7ZV;./A%?[V>0S_P!/<=/]I;>Q/>2L[GYG73Y:4JZW3M%/;+ I
MG-=T#N@G%1-VD3N2;J.=;)W]=LZ4[A[%QNS"R)%]  Q$ _$,XO!NN[FY$J^X
MG&*7=PN2?^9-GTWUCY%ER+T0Z;2NQ<<O7,75=6NI]^1?Q[-AKPEAX^++S;[S
MJ]\0?<\-K'RS*T>9<M6Y^0/&W:VKH#[DPD%:R0DM2=PMT$%.\I 75@]7R!2E
M-U[Q'M .X2YRDMQ\Q6GM:\"TQR)>, 8 P#@1Z!UP"H9^2WN"%W)YG.7K^NN4
M7D/K^1UWJ CE%0B@#-:TUE4:[<VJAB&, +1EY0DVABCZE%#H( (" 3CN->ZT
MY$LCX8>E4ZMP6Y";R=-%TY';7(9Q5X]RJ! 26KNM*=7DR&:!T]P2GGK.](J8
M1[1,@   "4>M+MKY[N]KBE]C;^^OW'//6\NYRY8Y<K3 LYE_)2[[EZW8M-OR
MACQ2\Y=ZI,?R9Q)A#DMHZJ\F>/F[./%W)W5/=VJ[YJR=5*B@LNQ8WBLR5=/*
ML0<)+))2<.9^#IJKVB*+E$BA?S% <#\"DUO%5V]P<Y76"JN7#JH[OXK[R6;M
M))$ATUH>_P"I;F5S#SK$#]ICH%EH5%XV/]%$A(8/00R>]&JZPEY%TEPBY/5C
MF?Q*X^\I:C]JE$[NU=5KLXCFBHK)5^R/&)6MSJAE3'5,=Q4+@T?1:W4QA]UF
M8.H_7(&UV>!5<?(YYKO^:7E1WVY8O17USQQDG/&#6;8BAQ;_ *?JF:EV-WFR
M=#F;N!LFT'DTZ1<$*45(XS0@B;V@,,XK8:]QUEY$V3XHG Q/BQX[&O("TQ)V
M6UN9DPUV8].[1*1Y':E@ ?Q.IH<H&3*JDWDV3I].^H_VA)=/K_DRY![6707#
M'Q)16"0P8>XJ$/DL?UJN:?\ KK5G\$M<9*.[VE%SXR6C\*_^G[RB_G%E/X*:
MAS$MY9:^'VDQ[,%@P#61S$\.7C<YW+RLSR*XL:\G+W+^X=UM6GMG>M=JJNS=
MXIO9"]T)U7YNQK-SG$Q$Y8[]L(C^9(P>F*F&D]Y%0YZ_#4K]>H%QV#X_-]7R
MQVVOQTI.QFB][)UN37MX,T5WW[LU'9-5AZHA&S3E,@(1Z<I&*(+K"0KAZB!C
M+%EQ=Y6[2:V;R$3K78V[>(>^ZUL>A2UEU%OC0]_"0BWGL*QEBJ%UJ<BJSD8J
M7C'B8 <I%T5V,E'NTSH.FYUFSA,Z2BA#9WE2;@Z]I<V^,SFA"^0?@YQ\Y:Q+
M)A#R&TJ64UVKD:HJ=C6-E5>1?U+8]?8E<K.'I(IA<X1Z# 5SF64CS(*&$1/U
M&%*;#:3JJH[W=0#ZB ?W\ J>/E%\[5>8/DVN^MJS-J2&HN'+-SH"I-47)E(Q
MSL&.??>;OL:;;O.@E)JWL@P*JI![7#2MM3^GTR451%%R573L)(/PY."*FK.-
MFVN=MU@CM+9R.FAUMJQT]:"F[0TYK^3[YZ48*J$!0K"Z[%1.F< $"JEKZ"@=
MP"4<PWM)VXTC7M9-'S!8>LFX>+L4-+5^<CVDM"SD:^AYB+?H)NF,G%R395G(
M1[ULJ!DG#1ZT6.FH0P"4Y#" AT' *6KRU\)97Q\\_P#D1QL5CWC2GP5Q=6K4
MCQTDH4DOJ&['/8:$Z;KG*4KL8V)>!&N5"=2@^8KDZ]2#DXLUYKAEX%DG\93G
M,\YI>+K645;I925VMQ9E''&V]N7KOWY25AZ?%QDCJVRKE545>JI/M;2\?'J.
MEC&,\DHIZ?KU P!%[&70?%&O:2%<P2*B#Y-']:KF-_G6H_X)Z\R<=QKW?C)C
M?PW/Z4NP_P"=+;G\*]#YB6\MM_ B6)D29Z>P5Z"MD)+5FT0T58ZY/QSV'G:_
M.QS.7A)N(DFZC20BY>*D$7#&1CGS54R2R"R9TU4S"4P" B& 5\/GJ^,5-T.0
MM','QGZ[?SFOG?W4[MOBA4&+B0G:,\,=9U)6[1T(V34=R]*6*8#N:NW*H[B3
M]QHXBK$Q6D?)2[RJ=NNU$'Q-22A9(BJ1WT3+Q#XJB:B9EV$E&23!P!B'(<HI
M.F3UFZ1Z@(=JB:A?P$,D4K8>^O-[NFSK;.7W8MKL%XN]F=A(62W6J6>SMDGY
M'V4D#R,U,R2SB0E)!9-$ON+KJ'54$.XYA,(CA+L#;;J]Y9H_#8_I4;,_G8VU
M_"/0&0>\V+?P(T3?-1_Z^N+/\H#'^-&ULE'<R%[L.T?PBO\ >7R%_P"H^.O^
MG[=S$C-K<RP R):>"A"J$,0X 8I@Z& 0 0$!]! 0'J @(8!#/\\WQG*CR6C+
M-RO\>-%KU#Y&L@7F-B:%@$HRJ4/>39--==_,TQB5%E!5+;:JG:<Y.]K&3H]Q
MEA2?&%=SE.F_<0G#B6SXBN2NE)N6M[98:'L*IV2BWBI2KN"M-.N$))5NT5N:
M8*"B]B9V!F&S.4B9)HJ E417234(/H(!DS7HTS]MSV-?MC#5S7ZYV>Z*4FH1
M- J*UHFI"=<5VCP"[Y>!J42XDEW*[.NP9I)8K)H0P(-$C^VD4B92E &V]Y.$
M^$P];1T_Y%Y!XJ5%HPJG'QXZ6./0B+=L]W NNJ81^A4TTQ$?[F5W9QMQ=R3]
MU)M^2VFY@X][+O0Q;"<K]RY&,4M[E)T2]K:/ODN,\SY2^#'E@U_!QXV#>+RW
M4GEGJ*/Z>_*O]C5Z;V=/.X:,3,)UOOKE 2DA"$Z>@K/TP'Z!TX#1I25R2G\3
M@F_.KKM[=_WGK5^9KR7:Y3Y3Z;:5AP4<'3-,R=/BTMB6/:P(PC5;-T&U[2#U
MQ\W9L3B?R&U-ON@G<PNR=$;.K%]A6SP7L>/ZU3)UL_<UZ=03,W=_I<L5HK'R
M34W3WFBZR*@"4YBCV)[4>12?"Z]I<Z^/7GMHKR-\9J-R0T98&+ME8(]HUO%*
M/(M'-IU;?$6J0V"AW%@@H*\?)QCSN%NH<A$Y!D9)VAW(+$,,-VQFTJ/:MQWA
MZ]?I@# & :N?+3Y.]0>+KBG<]S7>7A)#:,Q%2<#H+5:[]$L[LK9"S7VXQ)&,
M(<7W[I5MPX3>3;X" BU9D[.[[A9NFJ2JZ&&U%5*<N9E=F<BMR2LV]+,["W%O
M39CZ4=D9ME9"PWC9>S;2J[7(U:(%.N]F;+:)L032( G476 H (B&6&LZR?BR
MYR\5O#1KP%X"\:^, I-0LU#U^S?;'=M **4CM&WN%[;L-T18H!]PW2M,PY;M
MSCZBU02#\,K-E*BIW&PC!D8!6J_,/X*CJ#EMK+FU3X &=(Y0UT*CL-VQ9^TR
M;;JUPR0:I.WZJ1"HIO;GK_[,Z7</N.%(=VIZB!A&4>XINQW,^X\''F0B.'GA
M6\B.OK)<4R;6XV/7UQXS0<I((_<N5N1;-G3JY#5B/5,51Q&T[<K9U/R)4P-[
M9)=50WH( )JK\"4)+@?@1A^ '&2U\]^=W'3CFFE-6%YN[<]>;["E$%%7,LTH
M82PV;;US=NS@JH9:"HK"4DE53]1.='ZB8P=<MT15%<4B[)J55KU%JU<I52B6
M4#5:C!1-9K4'&H)M8Z&@8)@WBXB*8-D@*DW9Q\>U322(4  I"  9 V3Z' &#
M#W%0A\EC^M5S3_UUJS^"6N,E'=[2BY\1+1^%?_3]Y1?SBRG\%-0YB6\LM?![
M?V$J;E'ON#XL<<=Y<E+17K!;*SH?5EVVS8JY52L#6.7@:) /K'+M(<)1VPCO
MOC1\>H)/?623 0_,8 ]<P6$:GCW\O7@[R"WOIC0\=QZY)4B2W/M*AZKC;?<#
M:I0J=:D[_9XRK1TS8W$??WKUO",'THFHZ4214.FB4Q@*/3IF:-$%<C)T5:DL
MT!Z@ _M !S!,YP"HL^3?1J+1/,YRL:4-*-:M;&EJRZV5E%I-T&[6[VO5U3E;
M4=9%J4B19"4DEA?.C" **.'1SJ=3F,89QW%%W9(F*_#AD9M[XHKXVE5G2K&(
MYF;=CJT1P=0R3>$5UGH^6719%.(E3:FLDG(*&*3H7WE%!_PA,.1EO++?PF\+
MR@\T8#Q^\&.07*2941-*T.E.V6OHQ42=9_:5J.G6]=PQ4SG3%5!:T23=9T!1
M[B,D5C@ ]G3,;>PDVDJLIM]+:QV/S)Y1ZTU+%/W,WM/DONVM4\)R1^Y>*.+9
MM.YM6,A9IM5%-=P+5N^F57[Y?M-[:)%%#>@".6;D:R]^6TNV^.>C:5QFT/J+
MC[KID5A2-.:^JNO*XB"94U%8^L0[2,!^Z @ 4[^460.Y<G^JCA4YA]1'*S:\
MMQFG & 0A?F;<)D+=H[0O/2J0YU;#J&THZ.VN[9H )AUQ?CR$K1IV56 H 5E
M6K^V/&D,81,*UD3* = ],QWE=U5C7N-'?Q1>>R?%/R'):"N,N=EJ[F9$,]9G
M(NL!(^,V_"K.I+5,LJ"BA")GE7#I]!=0]3*RR/7J! Z2EN(VG1\/>6GI1ZE
M?VAD"XJ(?DT?UJN8W^=:C_@GKS)QW&O=^,F+_#94*?Q3[((7KU1YJ[:3/U#H
M'<.I]"*^@_B'8J&1EO+;?P(ED9@F, 8!#X\Z_P 9BG<PE;ERSX*1]=UORB70
ME;+L+4AO9@M?<@9))%Q(/)&'521"/I6WIQ<!+]PI[,1,NU .^.U6.N_-E/["
M$H*6U;RMKO=$NFK[E9M=[&JL_1[W3)I_7;94+3%/(2Q5V=C%S-G\5,14@D@\
M8O6JQ!*8AR /X_00'+$:[36QEFC\-?\ I4;,_G8VU_"/0&5O>;%OX$:)_FH_
M]?/%G^4!E_&?:V9B0N[D=HOA%?[R^0S_ %'QU_T_;N)&;6YE@!D2T8 P"/'Y
MM? )I7RHUQ7:5"=PNFN95:A@CZSM [)4E7V+',BJ'CJ?M]I%-7#]ZQ0,<4V<
MR@BO)1I! G8Y;D*V#*=/(C**EYE6KRAXN;SX:[NNW'KD709C76T:'(J,I6&E
M$3_:23$RBI8RS5F4 @,K'4K W3]^/DFIE&SM 0,0W4# $UM1KRBXNC):'Q)Y
MA:NZ7\R%@;J&1<0?&ZF3""I#=ATEHRJ[\>I*%-Z=IB*(@(#Z=!S2U!N.%>DM
MZM3_ /"S],Z+X%O5>K?*^F74I6LGF33+4D]J:N9EF#37;5,VH_'[V&E6N75W
MH;E8$T]E:BF$F:9N@ O+U&8BIU @")@'W"Q)GQ@  $>@#G!Z?+AS(_\ -&4?
MPE_\I[<?FB\JSU?H5IW,UJ-9Z1KMIS?=:RK5RRWY?-^2O:C55\E_P(7?3VPM
MH^1WB95G%ET9?)B1OO(W6T U<NY[3EQFG#F2MVT(J,015.]U38I-0[^4,F(G
M@'KE50Q"QH][/LZ?>> %R%:R1&\\<7DUY1>+[=A=Q\<;*U^TF&Z$3L;6%I(Z
MD==;.KJ*_ODC+/#MW+59)^Q4$QV$DU41?L5#&]M04E%DE<M5*XS<7X%@?Q ^
M73XTMX0T5'\C";%XA;",W;DF$;;5YC9.LW,F=,/=+7+SK6-G9P6/N%'^TF(.
M(*GU !,< $^1X6BY7(OP-I*OG6\0:,2::/Y!N-YFA&IG@HI7(R\K[()"KV%@
M4&*DXHZ$H=/8*W%<3?E G<(!F-I+BCOJOM1J)YG_ "_/'QIN!G(;B=!; Y:[
M(^U62@I-&MS&K-.M)  ,0BL]9+VTB+V]005Z&!*.KZR;DH"4'274#YFC]A%W
M(KQ*^/G?SZY*>1K>\OR Y-7/]Y+.Y;!#UBNQ2!XRDZ[J:+E=VQI]&@!7<%BH
M5HLY.H<RBBSMVN<RSE998YCC-)+<4RDY/;N)@OQA_ ?:V%GUWY->8U4"$BX]
MDVM_$K4%@:+$G7\D]2(M!;]N,6[0(G%Q;1DL#FHM5.YRY64)+&(BDBP4=1;[
M%N+80I[SWD_$ Z  !^  '_PR)8<X P#2S\@'@NMSZ\8N]M;UN,"2VMJQJCR$
MTRB5,ZKIU>]6,)5Z]K[!-,ASK2-VH4A-0;0@B4GWDDB8X@4@B!.CJ8DN)4*>
M(BRR::J1%5")+@0%DRG,5-8$S=Z8*D 0*H!#^H=>O0?4,L-7:B>W\,K@8L"F
M^_(O=8@@(B"_'#1:CM(PJF.!H>S[BMK--9,"E1 /T6&9O$1,)C?JK<1#M. Q
MDR^TJ)OO)]&1+!@#!A[BH/\ DL?UJN:?_?-ZL_@CKC)1W%%SXO82TOA7_P!/
MWE%_.+*?P4U#F);RRU\'M_82N>1>HF'('C[O/0TJZ%E%[MT]LS4<F] HG%G'
M['I<U3GKKM+U,;[=M,F/T !$>G3,%A2&[UTOM;B5O_8FD=E1TC2]M:0O\E6)
MI-([AFZ83M:D>K"<AG@ BL=@_321?QSM/H"S95)9,>TQ1RS>:K3B_%%E3XI?
ME!\*N1VC*13N:VW*WQHY25*"C:_>9#8B;B"UAM!]%,D6JVPZI=T6RM7@#6#V
MP7>Q4HM'+-'JBB;4'#8I%<@TUY%ZG%K;O.S7-WY,7B\XG:YGI77F]JORMVVI
M%/\ ]Q]8Z!?$NT=*3OVRQ8P]LV*R$*)5:TG(^T#U7[]Q)E;&,=JQ='+[8DFS
M+G%;VBK6Y"[RW!S:Y-;&WG?BO+=N/D#LAS..8J!8O'JSN=LK]%A7ZC5HE'[I
M\JTCFXM8N+:$]Q4$$44B]QNG6>XUVW-^);V^%O@Y+>/'QQ<>.-UO1:I[.80D
MI?MOBS5*X23V;LB7>6RPPP.DP!!Z%.1D&\&1=/\ LUTXPJA1$#=1K;JS92X4
MD:-?E4:#\DW-5#CIQ?XA<8=E;:T?6T7VZMH6ZG#"EBY/8ZSJ;IU-J+O]3GXU
M0R]1@$'T@J3VC$,,RW-W=R8 &51;2,U)JB.CGQE?!IRCT)S5LW+3G#H&UZ;1
MT32%FFBX2[?H2BUEV7L9O+5J4M+-O&24N!VE&HY9%$WN@D)7LRU62,)D# &9
M.JH8MP<75[R?[D2P8 P#K3S&XQ47F;Q=WKQ<V.0?W2W=KF?I#M\1%)PYK\H]
M;@XK-NC4ERG1-,4VSM6<JR[P,0';-,1 0#I@;]Y5$Q_@8\UVJ=CLYVG<*-R!
M9M;W9"5J]SJ[NIJ,_P!<I\Z5W"V:NR V9NLJU%_')NFBW80QB=AN@=>F3JF4
M?+FG5?J+9GC'<]F;$XZZ.O&Z:+):RW'9]5T:6VQKV5;)M'E.V4YKL>-ZK_LH
MO'Z0LXZS@Z3;'*LH"C8$S]?S9 O*[CSW^'[R7\GO*OR@W;H/A_M+9VJ;DYUJ
M:KW:O!6OTB:+#ZHI,))&:??S[)UT9RT<N@;N3+^=,>G4/7))[*%-R$I2JB3M
M\7+B1R2X7^._8>I^4>HK1I?8<IRQV->8ZJVT(X))W5)?6&E(:.G$OTM_(MOL
MG<G77J)>J@'[VQ^I0#H(X>\L@G&*3WDD3,$A@#  ^H=/VX!H"\T7@2X^^56H
MN+Y7S1NF.8-7AUDJ9NB.C$0C+RDS9J$C*/NEDT;&=V&L^X!"-9)'_P#MH<>A
MD3+M@48KY3:W$914EM,?_&%XG;[X3<&-]<>.25 E-=[/IW-[:IG<8^[7$=-0
M[S4FA!B+559IOW1]DJDXBD8[1\U.=%3M,0>U5-1,A[Q%.,:,U _*K\9_/#FU
MS)X]7_BIQGV#NRF53C*TIUAL%1""^QBK.3:>Q9L\,Y_59F-6^[+%2K9<>TAB
M]BQ?7KU ,JGM(W(N5*'8+XG'CZYG\')_FLXY8\>[SH]OL6(T@C2UK@$-V6%6
MMO-EJ3:; 8J6DA[XXLPV%3O OHL7IU]>F'M,VXN*VDSG,$Q@# & :N_*)XF.
M+/E4TX;7^\8 \%L2MMGBNI-[55FP3V/K&77 R@(M7KA$Q;!29-SV_JD$\$6;
MPG]HF+9XFV>(*T,-*2HR.1X9/%_R>\9[+S7Z,W_61.PL?%V*5U9M* 2<.*%M
M:N)U3D R)+UF143ZMY%L9PD5_%N.Q]'JJ%!0@IG255U=1?%@WJ;_ )4__"S]
M1Z%78X76KE#)G\%OFG29/RCG6&_N1TIX,;H_Y?>6NB-JKK@WBH"_13*QJ&'\
MA:M9!4K5E.I^8H=$86664#U]#$ ?7ITSK,9NU.-U?N23]BW_ '5/Z9_4CT]_
MW2Z&\R\DVX\>;E:9<G87;]3CTR,=+SO6H1\FT6(#YC%ST:Z82+5E+P\LQ79O
MF+Q!!_&R<;((&1<M';5<BK9XQ>M51(HF<IDU$S" @(#G;]C55N/Y2IQE"3A-
M-33HT]C36\AL^3SXB>BM\2MEV_X^K?'\<-E3;Y>7D]*6[[AUQ]E'*Q%5'2=-
M5B(MY:=7+O'AO<^W3"4B$^[VF[5DD =))T\BJ5N,MNYD-_D=X)O*_P 8)=W'
MWWA?MVT1C<ZGL6[3D&IN:I/T2&5*5PC)ZY_>!=F54J(G!-Z@U< 3H)DR]0R5
M45.W)>)T12XE<JUY((9'C-R"5ES+ W"+3TSL8\B*XG!($09%K8N?=]P0+V]O
M7N]/KBJ(\$NYFP[C-X!O++RFF6#"H<0-CZ\@G:@%<WC>T>?354C4.XI5'*Q[
ML2.GY(B)3=PIQ[!ZX$ $"IB/IBJ)*W)DTGQ9?$[XU\49FJ[IYJV".Y5;N@'9
M)>(H"$>+;CK4))($%F+AQ7I=B6=V9,13I,YDUI4S:)-WAUBS*)D6R+;9;&"C
MMWLEUIID13322(5-)(A4TTR% I"$(4"D(0I0 I2E*'0 #T ,P3// & , \3%
M W3KU]/V8!3T^</QX2_#3RM;8X\ZSJ[M6G[PM<'M7CG 1S8!%[5MWSCLD73X
M)J@F7JVJNQ"2M;9D_,H9*,3,81,;J,T]FTU[D??\RU"\<W$V$X-\(.-'%B%:
M-FR^I=65Z*MKAIT,C,;(ETCV7:-A(H!$Q.2P;$FI-X0!#J0BY2]>A0R!L425
M%N.ZV , X-UZ#T]1Z>@8!6;^>#P]^33DYY5>56[M$</-I[+U5=I;7BU5NU?"
MM?I$VE$ZGHT'(*,_O[ S==K66C5T#=Z9?SICT].@Y*+213<A)RJMQ)$^*MPT
MY1<)N&7(+7?*K3%LTG<K3R>D;G 0%N_3/OI6L*ZIUI")3+7]*D9) 6AI6'<H
M?F.4W>B;TZ=!'#WD[<7&-'WDH7,$R.9YO/C[ZB\JK-+<>NIR-TIS$K,*E#1F
MPG$>HXIFTH-@40BZKMAC'HGDA4BR]4XZ<:%4>L43"BJB[0*BDB3:(R@I>97@
M\G_"1Y1>)=ED8'9?#S;UAC&1US-;UJ*KRFWZ#+,D5#$"09V.@M)LC-%0I>_V
M7Z;-VF00%1$G7IDZIE#MR6[:C"VE_&%Y#N05E8535'#'D;8Y*0>I,"O'>J;=
M6:XQ64.!14F+9:HR%K$*U0 >Y55V[133+ZF$ Q5!0D^QD]GP4_&:C.#-TJO+
M[FI(5[8?)NO(JOM9ZL@3MYS6^E)9VFB5&VOI99J4+EM*(2]U-DNCTBXA18R[
M?[EV1J\;1;KY%T(*.WM)@.8)C & , 8 P!@# & , 8 P!@# & , \2E @="^
M@?\ Z '_ -L \L 8 P!@# & , ^=M-<9VFKV6KO2E.RLL#,0#TJA04(9K,,'
M,>X*<@@('*9)R;J _4/3*KUOYMJ5I;.*+7VJARFB:I?T36<36L9M9.)DVKT6
MG1\5J<9QH^QUBBLWGX21K,]-5R60,UEJ_+R4))-CE.FHWD(EXLP>HJ$.!3D.
MBY0,40$ $!#]N=1A+BBI-4JC^P/2]1Q-8TS'U;!DIX.58MWK<E1J4+L%.#36
MQIQDG[2?)XO^1\?R6X::DLQY$KRXTB"9:MV(@JY!S(HVNC,6D2$C(F$YE!7M
M,(1G+=P^@_>B7ZE, =CTV\KN,HOXX>Z_);G[52OC4_F-]9/27*Z0^H#7='C:
M^7H&HY,]1P9*/#;>-F3E=^7;V4IC7G=QJ+_13W-&P;.0/EHX$ $>OX_^& <=
MH?\ ;^]_?_#  % !ZA_]< \L 8 P!@# & :R^5'C$TKRIYL<(.:=U:L5+?PX
MD+P[1BW$8D[)>6\M'&>Z]:R;@XAVIZTV"(SC IRG*5PLKV]HF$15%$W7M1LT
MP!@# & ?E?/6L:R=R+Y=-JR8-7#UXY6,!$6[5JD==PNJ<P@4B:21!,81]  ,
MA<G&W!W)ND(IMON2VLNQL>]EY%O%QHN>1=G&$8I5<I2:44EVMMI(_04P&*4P
M ( 8 'H8!*8.H=>ABCT$I@_$!]0R2=54J:X6UW'EF3 P#Q["^OI]1$?J/U'U
M' '87U]/4?J/4< \L 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8! 3\KFEG&D.=N\X@K8&\)>[!_Q<K1R$$B+B,V/[D](^P02D J3"U*2+,
M+U+U;#T'\ ZE?M_*OW+?8INGD_>27@DZ>SVG]._HDZA6NHWIJY;SG/BU'3,7
M^F9";JXW,"EFWQ.KVSQE8N[=O\3:9I\-O-!/B[R/1H=R?J(:EWXY@Z9/JJ*
M#.M7,7PM:1;EA5.1)LQ1>22K&04$2E(T>"N<1!L4,MQ+_P!/D*;_ )<MDO+L
M?^'[DWVGY[Z_/3Y/K-TEES-H%I2YYY8A>R["2][(Q.#BS,543<IN-N-ZQ':W
M=M*W&CO-DX(! 0ZAZAG:*U/YRFJ;&<X P!@# & , 8 P!@# & , 8 P#J1R%
MV0D[V%I'C17G9%+=N2TELML;HG$58/1^LCDME]DI(J8',DQNCZ.951,#@7WA
MFE1(8!1,(<9G3^;.&#'?<DN+^XMK7^*C7CM/W/I9RE.QRKS'U?U6#6A:!A?3
MXTFME[5]03QL*W;;I6>)"Y=U*5*\/TD%)-7%7ML'TSDS\,9S@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P"-S\@SC.YL=)UIRH@6
MJ[AY01+K*^@D7O*E4YN1=RE5E% *43)H1=F?.FYS"/032:?7Z9P>JVFIQO\
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MH*3]RU"NZW9MJ-JVNR$(HRMEYTD8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M<#TZ#UZ=.@]>OTZ?CUZ^G3,/<95:[-YB6P?\"?N#?O3_ ,)ONN_\_P"\'[G>
M_P"YU'KW_J7]IW_7Z^N:$OZ7Q>_]/Q^/!4[QI?\ N3\I?T7^N?)IL^1]52GA
M\O90_76?^#'O$_<[_AA]QW_V7[M?NK[W?W#_ )/]+_/W=?V>O7%O^G<?\/Y'
MS/#@K]Q1K'^X'RW_ %[^L?*IM^H^II3Q^9L^TRAG('31@# & , 8 P!@# &
), 8 P!@# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm213941d2_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213941d2_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  D ,,# 2(  A$! Q$!_\0
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M56-_::U8>=;DR02 J0Z%?J"#5#PKX5M/"EC/;6>6$T[2EB.<'[J_@.* ./\
MB9_R.GA'_KX_]G2M#P^ITOXI>((+SY'U!$GM6;I(HX(!]1Z5SGQ)UG[9XIT>
M73+:>Y_LUR\C"%]F[</ESC_9[5V8;4/$MC%,UAHUU!G*&224%3[90$&@#/\
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944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm213941d2_ex5-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm213941d2_ex5-1img002.jpg
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DC+Q\I]QBK%MH]Q:22RQV>GF6;'F22222.V.F68$X&3Q[U__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
